CRISPRimmunity

Please click to download your results

Overview of predicted results

Overview of the results

Contig_ID	Contig_def	CRISPR array number	Contig Signature genes	Self targeting spacer number	Target MGE spacer number	Prophage number	Anti-CRISPR protein number
NZ_CP034089	Bifidobacterium longum strain LTBL16 chromosome, complete genome	4 crisprs	cas3,WYL,DEDDh,casR	0	1	0	0

Cas Category Instructions

Results visualization

1. NZ_CP034089

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Crispr_ID: NZ_CP034089_1

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP034089_1

297529-297614

Orphan

Consensus_repeat	Method
GACAGCTCCCGCCAGCGGGAGCACTT	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP034089_1

>merge|NZ_CP034089|1|297529-297614|CRISPRCasFinder
GACAGCTCCCGCCAGCGGGAGCACTTATTTGTAGGGAAATTCTCCAGTTCAAATCCGTTAGACAGCTCCCGCCAGCGGGAGCCTTT

>NZ_CP034089|1|1|297529-297614|CRISPRCasFinder
GACAGCTCCCGCCAGCGGGAGCACTT	ATTTGTAGGGAAATTCTCCAGTTCAAATCCGTTA
GACAGCTCCCGCCAGCGGGAGCCTTT

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP034089.1\|WP_007054751.1\|294366_295908_+\|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatA	unknown	unknown	gnl\|CDD\|234572
NZ_CP034089.1\|WP_007056503.1\|303182_305252_+\|transcription-termination-factor-Rho	unknown	unknown	gnl\|CDD\|237171
NZ_CP034089.1\|WP_007051538.1\|290580_290862_+\|metal-sensitive-transcriptional-regulator	unknown	unknown	gnl\|CDD\|224848
NZ_CP034089.1\|WP_007056480.1\|306070_308155_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_155661277.1\|285029_286709_+\|phosphoenolpyruvate--protein-phosphotransferase	unknown	unknown	gnl\|CDD\|224006
NZ_CP034089.1\|WP_155661478.1\|290925_292329_+\|DNA-recombination-protein-RmuC	unknown	unknown	gnl\|CDD\|376878
NZ_CP034089.1\|WP_011068472.1\|297755_298793_+\|GNAT-family-N-acetyltransferase	unknown	unknown	gnl\|CDD\|379112
NZ_CP034089.1\|WP_011068470.1\|299324_301145_+\|histidine-type-phosphatase	unknown	unknown	gnl\|CDD\|132717
NZ_CP034089.1\|WP_155661479.1\|311259_312726_-\|ABC-transporter-substrate-binding-protein	unknown	unknown	gnl\|CDD\|173859
NZ_CP034089.1\|WP_007051524.1\|305559_305949_+\|chorismate-mutase	unknown	unknown	gnl\|CDD\|181719
NZ_CP034089.1\|WP_013410392.1\|287760_290469_-\|HAD-IC-family-P-type-ATPase	unknown	unknown	gnl\|CDD\|319774
NZ_CP034089.1\|WP_007051527.1\|301363_302977_+\|NAD(P)/FAD-dependent-oxidoreductase	unknown	unknown	gnl\|CDD\|235967
NZ_CP034089.1\|WP_011068468.1\|308380_311221_-\|valine--tRNA-ligase	unknown	unknown	gnl\|CDD\|380147
NZ_CP034089.1\|WP_007051520.1\|312847_313534_-\|endonuclease-III	unknown	unknown	gnl\|CDD\|223255
NZ_CP034089.1\|WP_080549165.1\|292397_292955_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|234771
NZ_CP034089.1\|WP_007051535.1\|293048_293897_+\|RNA-methyltransferase	unknown	unknown	gnl\|CDD\|349969
NZ_CP034089.1\|WP_003828150.1\|298803_299118_+\|DUF2469-domain-containing-protein	unknown	unknown	gnl\|CDD\|313765
NZ_CP034089.1\|WP_011068473.1\|294063_294363_+\|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatC	unknown	unknown	gnl\|CDD\|178810
NZ_CP034089.1\|WP_013410393.1\|286942_287677_+\|aquaporin-family-protein	unknown	unknown	gnl\|CDD\|223653
NZ_CP034089.1\|WP_007051530.1\|295933_297433_+\|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatB	unknown	unknown	gnl\|CDD\|235489

Protein	Function_ID	Function_description	E-value
NZ_CP034089.1\|WP_007054751.1\|294366_295908_+\|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatA	gnl\|CDD\|234572	PRK00012, gatA, Asp-tRNA(Asn)/Glu-tRNA(Gln) amidotransferase subunit GatA.	0
NZ_CP034089.1\|WP_007056503.1\|303182_305252_+\|transcription-termination-factor-Rho	gnl\|CDD\|237171	PRK12678, PRK12678, transcription termination factor Rho; Provisional.	0
NZ_CP034089.1\|WP_007051538.1\|290580_290862_+\|metal-sensitive-transcriptional-regulator	gnl\|CDD\|224848	COG1937, COG1937, Uncharacterized protein conserved in bacteria [Function unknown].	2.43596e-30
NZ_CP034089.1\|WP_155661277.1\|285029_286709_+\|phosphoenolpyruvate--protein-phosphotransferase	gnl\|CDD\|224006	COG1080, PtsA, Phosphoenolpyruvate-protein kinase (PTS system EI component in bacteria) [Carbohydrate transport and metabolism].	0
NZ_CP034089.1\|WP_155661478.1\|290925_292329_+\|DNA-recombination-protein-RmuC	gnl\|CDD\|376878	pfam02646, RmuC, RmuC family. This family contains several bacterial RmuC DNA recombination proteins. The function of the RMUC protein is unknown but it is suspected that it is either a structural protein that protects DNA against nuclease action, or is itself involved in DNA cleavage at the regions of DNA secondary structures.	1.30261e-105
NZ_CP034089.1\|WP_011068472.1\|297755_298793_+\|GNAT-family-N-acetyltransferase	gnl\|CDD\|379112	pfam13302, Acetyltransf_3, Acetyltransferase (GNAT) domain. This domain catalyzes N-acetyltransferase reactions.	8.65156e-13
NZ_CP034089.1\|WP_011068470.1\|299324_301145_+\|histidine-type-phosphatase	gnl\|CDD\|132717	cd07061, HP_HAP_like, Histidine phosphatase domain found in histidine acid phosphatases and phytases; contains a His residue which is phosphorylated during the reaction. Catalytic domain of HAP (histidine acid phosphatases) and phytases (myo-inositol hexakisphosphate phosphohydrolases). The conserved catalytic core of this domain contains a His residue which is phosphorylated in the reaction. Functions in this subgroup include roles in metabolism, signaling, or regulation, for example Escherichia coli glucose-1-phosphatase functions to scavenge glucose from glucose-1-phosphate and the signaling molecules inositol 1,3,4,5,6-pentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6) are in vivo substrates for eukaryotic multiple inositol polyphosphate phosphatase 1 (Minpp1). Phytases scavenge phosphate from extracellular sources and are added to animal feed while prostatic acid phosphatase (PAP) has been used for many years as a serum marker for prostate cancer. Recently PAP has been shown in mouse models to suppress pain by functioning as an ecto-5prime-nucleotidase. In vivo it dephosphorylates extracellular adenosine monophosphate (AMP) generating adenosine,and leading to the activation of A1-adenosine receptors in dorsal spinal cord.	3.0389e-06
NZ_CP034089.1\|WP_155661479.1\|311259_312726_-\|ABC-transporter-substrate-binding-protein	gnl\|CDD\|173859	cd08494, PBP2_NikA_DppA_OppA_like_6, The substrate-binding component of an uncharacterized ABC-type nickel/dipeptide/oligopeptide-like import system contains the type 2 periplasmic binding fold. This CD represents the substrate-binding domain of an uncharacterized ATP-binding cassette (ABC) type nickel/dipeptide/oligopeptide-like transporter. The oligopeptide-binding protein OppA and the dipeptide-binding protein DppA show significant sequence similarity to NikA, the initial nickel receptor. The DppA binds dipeptides and some tripeptides and is involved in chemotaxis toward dipeptides, whereas the OppA binds peptides of a wide range of lengths (2-35 amino acid residues) and plays a role in recycling of cell wall peptides, which precludes any involvement in chemotaxis. Most of other periplasmic binding proteins are comprised of only two globular subdomains corresponding to domains I and III of the dipeptide/oligopeptide binding proteins. The structural topology of these domains is most similar to that of the type 2 periplasmic binding proteins (PBP2), which are responsible for the uptake of a variety of substrates such as phosphate, sulfate, polysaccharides, lysine/arginine/ornithine, and histidine. The PBP2 bind their ligand in the cleft between these domains in a manner resembling a Venus flytrap. After binding their specific ligand with high affinity, they can interact with a cognate membrane transport complex comprised of two integral membrane domains and two cytoplasmically located ATPase domains. This interaction triggers the ligand translocation across the cytoplasmic membrane energized by ATP hydrolysis. Besides transport proteins, the PBP2 superfamily includes the ligand-binding domains from ionotropic glutamate receptors, LysR-type transcriptional regulators, and unorthodox sensor proteins involved in signal transduction.	0
NZ_CP034089.1\|WP_007051524.1\|305559_305949_+\|chorismate-mutase	gnl\|CDD\|181719	PRK09239, PRK09239, chorismate mutase; Provisional.	9.5939e-49
NZ_CP034089.1\|WP_013410392.1\|287760_290469_-\|HAD-IC-family-P-type-ATPase	gnl\|CDD\|319774	cd02079, P-type_ATPase_HM, P-type heavy metal-transporting ATPase. Heavy metal-transporting ATPases (Type IB ATPases) transport heavy metal ions (Cu(+), Cu(2+), Zn(2+), Cd(2+), Co(2+), etc.) across biological membranes. These ATPases include mammalian copper-transporting ATPases, ATP7A and ATP7B, Bacillus subtilis CadA which transports cadmium, zinc and cobalt out of the cell, Bacillus subtilis ZosA/PfeT which transports copper, and perhaps also zinc and ferrous iron, Archaeoglobus fulgidus CopA and CopB, Staphylococcus aureus plasmid pI258 CadA, a cadmium-efflux ATPase, and Escherichia coli ZntA which is selective for Pb(2+), Zn(2+), and Cd(2+). The characteristic N-terminal heavy metal associated (HMA) domain of this group is essential for the binding of metal ions. This family belongs to the P-type ATPases, a large family of integral membrane transporters that are of critical importance in all kingdoms of life. They generate and maintain (electro-) chemical gradients across cellular membranes, by translocating cations, heavy metals and lipids, and are distinguished from other main classes of transport ATPases (F- , V- , and ABC- type) by the formation of a phosphorylated (P-) intermediate state in the catalytic cycle.	4.37103e-151
NZ_CP034089.1\|WP_007051527.1\|301363_302977_+\|NAD(P)/FAD-dependent-oxidoreductase	gnl\|CDD\|235967	PRK07208, PRK07208, hypothetical protein; Provisional.	0
NZ_CP034089.1\|WP_011068468.1\|308380_311221_-\|valine--tRNA-ligase	gnl\|CDD\|380147	NF000540, alt_ValS, valine--tRNA ligase.	0
NZ_CP034089.1\|WP_007051520.1\|312847_313534_-\|endonuclease-III	gnl\|CDD\|223255	COG0177, Nth, Predicted EndoIII-related endonuclease [DNA replication, recombination, and repair].	2.51632e-96
NZ_CP034089.1\|WP_080549165.1\|292397_292955_+\|hypothetical-protein	gnl\|CDD\|234771	PRK00455, pyrE, orotate phosphoribosyltransferase; Validated.	0.00200822
NZ_CP034089.1\|WP_007051535.1\|293048_293897_+\|RNA-methyltransferase	gnl\|CDD\|349969	cd18096, SpoU-like, SAM-dependent rRNA or tRNA methylase related to SpoU. RNA 2'-O ribose methyltransferase catalyzes the methyltransfer from S-adenosyl-L-methionine (AdoMet) to the 2'-OH group of ribose in tRNA or rRNA. It is part of the SpoU family of MTases, a subfamily of the SPOUT methyltransferase superfamily. The SPOUT methyltransferase superfamily is a large class of S-adenosyl-L-methionine (AdoMet or SAM)-dependent RNA MTases which are structurally characterized by a deep trefoil knot.	4.64827e-41
NZ_CP034089.1\|WP_003828150.1\|298803_299118_+\|DUF2469-domain-containing-protein	gnl\|CDD\|313765	pfam10611, DUF2469, Protein of unknown function (DUF2469). Member proteins often found in Actinomycetes clustered with signal peptidase and/or RNAse-HII.	1.30549e-58
NZ_CP034089.1\|WP_011068473.1\|294063_294363_+\|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatC	gnl\|CDD\|178810	PRK00034, gatC, Asp-tRNA(Asn)/Glu-tRNA(Gln) amidotransferase subunit GatC.	3.21183e-29
NZ_CP034089.1\|WP_013410393.1\|286942_287677_+\|aquaporin-family-protein	gnl\|CDD\|223653	COG0580, GlpF, Glycerol uptake facilitator and related permeases (Major Intrinsic Protein Family) [Carbohydrate transport and metabolism].	7.88559e-80
NZ_CP034089.1\|WP_007051530.1\|295933_297433_+\|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatB	gnl\|CDD\|235489	PRK05477, gatB, Asp-tRNA(Asn)/Glu-tRNA(Gln) amidotransferase subunit GatB.	0

>NZ_CP034089.1|WP_007051530.1|295933_297433_+|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatB
MAEKLMKYADATKKYDVVFGLETHVELSTNTKLFCPAHIEFGGEPNTELTPVSLGLPGSLPVINKTAVDYAIKLGLALHCEIAEWSQFARKNYFYPDMPRDYQISQYDKPTNGNGYLDVELEDGTVFRVPIERAHIEDDAGKNTHVGGADGRIEGADHSLVDYNRAGVPLIEIVTKPIEGAGDRAPEIAGAYVRAIRDIVRALNISHARMEQGNMRADVNVSLRPSPDAPYGTRSETKNVNSFRGIEKTIQYEIRRQAARLDDGKEILQETRHWDEATQTTAGGRLKSDADDYRYFPDPDLVMLHITKEHIEEMKAQMPEMPRERRNRLKSEWGLSDLQMRDILNADALDLIEETVKAGAKAAGARKWWLGELSREANAKGVSLEELPITPADVAEVEKLIASGKLNDKLAKQTVEGVLKGEGTPDEVVKKHDYKIVEDNGAIEAAVDAAFEANPDVVEKLKSGNMKPMGVIIGAVMKATRGQADAKAVTKVVMGKIKG
>NZ_CP034089.1|WP_007054751.1|294366_295908_+|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatA
MSNETATLVKLSAAEQAAAVKKGDVTSRELVEAHLKVIEAAEPSIKAFLKVSGDVALEQADAFDAKSAEDKAALPELAGVPIAIKDMIVTKGIETTAASKILEGWVPPYDATVIEKLKAAGMPILGKTNLDEFAQGSSTEHSAYQTTHNPWDTERVPGGSGGGSASAVAAFEAPIALGTDTGGSIRQPGALTGTVGVKPTYGGVSRFGAIAMASSLDQIGPVSRTVLDSALLQEIIGGHDKRDSTSIPEGPRPMVAAAREGAKRDLKGMKVGLIKELGGDGFQPGVEARFNEAVDKLKEMGAEVVEVSVPHIGYSLGAYYIIMPSEVSSNLARYDGMRYGLRVMPPTGVPQTAANMMAYTREAGFGDEVKRRIILGTYALSAGYYDAWYGSAQKVRTLIIEDFKKAFEQVDVLVAPTSPSTAFKFGEKMDDPLAMYMNDIATIPANLAGVPAMSIPAGLSDDGLPVGFQFIAPQQRDEVMYKPAAALEAALEDSWNGPIWNDLKTPWLDGLGK
>NZ_CP034089.1|WP_011068473.1|294063_294363_+|Asp-tRNA(Asn)/Glu-tRNA(Gln)-amidotransferase-subunit-GatC
MPTFSREEIVHLGDLARIALTDEEITRLQGELNVIADSINKVQEVASDDVPPTANPVPLEAYLRPDVAETPLTQEEALAGGPKTEAGMFVAPRILGSEE
>NZ_CP034089.1|WP_007051535.1|293048_293897_+|RNA-methyltransferase
MHAPNQISLAAKASGEPEFREIGLGPWSETHPGEPRPDDPTSSNYDGRFDSVLLNDGDRRNVLDRYRYWTVAAIKADLDARGRHDFEVAVENWTHDFNIGSMVRTANAFQAKRVHIVGPHKWNRKGALMTELYQHVEHHPSIAELVESWHHRIAGEIAYERAKAGAAAIHAHDVAVDGDNKHLHELLAEIDACDARIKELQAARVIALDIIPGAVPMEAYAFPKRCLLLFGAEGPGLSEKALALADDVVYISQFGSVRSINAGAAAAVAMHAWIAQHAVSGV
>NZ_CP034089.1|WP_080549165.1|292397_292955_+|hypothetical-protein
MLEPREQLATLLKEHVVGRPFSELAAVTFDHRAATVMGHVLIDALEDAGYSIDDFDAVGALTAASVPMVSAMIQAAASRGEGLDGFVMDFVYPSIKGPSIEGRRVVLLDAWLSEKSYVQTSSLVTLRNGNELSLDFGIVEQLGAKVVAIASLVGGGAKDINVVNPSTGDEQTLPFIQVFDESELR
>NZ_CP034089.1|WP_155661478.1|290925_292329_+|DNA-recombination-protein-RmuC
MIIVIVVLVVGAGLGLFAGFVLGRHKGQEMARGVKSEELEEAKTSLENARFENAELSARNAAAQAQIEGVNQQLAFAKSQLAQAQQAEQIRIQQERERAAAEAERKRQADAQAAEAKRAEQEARLKEQSKVLEALAPVAKNLDTLQNKVTQIEEGRKREMGALGAQLKGLNDQQARLDKETSSLSAALRNNKVRGAWGEAQLKNIVESAGLLEHVDFDTQVVVTDADGRTLRPDMIVHLPGGKTIPIDAKVPYADYQRACEIPDTASPEDIARRDDLLRSHAKALREHVRALGEKAYWNAFDVAPDFVVAFIPNEALLQAALEADSTLMDDAFSRKVALTSPVTLWAVLKSVAYAWQQQSLTDDAKQLFDLSRELYERFSTLGDYAIKLGTQITKTVSAYNKFASSLERRVLPTARKLQKIEPTKIIEEVPIIESDKGNVSELSAPEVVPADEGDTHLTASGDSLES
>NZ_CP034089.1|WP_007051538.1|290580_290862_+|metal-sensitive-transcriptional-regulator
MHGYDEDKAKVIARLRRIEGQVRAITQMVEDDKYCIDILTQISASNSALKSVALLLLDDHLNHCVRQASIQGGEVADEKLAEASAAIARLVKS
>NZ_CP034089.1|WP_013410392.1|287760_290469_-|HAD-IC-family-P-type-ATPase
MELSIFSAATALIAAAALTWLVLRFFFGTQKATAGAMDASGERQSATITVKGGYSPAVISMRTGTPITLTFDRQETGECTSHVVFADLGLDAMLPGNATTDVELPALPAGEYPFACGMNMVHGLLRVEGEESKDGADKDGLRPRADGSAEAEGVSPSDLRVGAPVVDAAEAERREAAERANEIKALTKLVIVGAVLTLPVFAVTMLHMTNPALVPHWMVNPWLQAILITPVMFYCGRPIHTVGFPALAHRSPDMNSLVSLGTSAAYLYSLVTCIAPWVFPEGSREPYFESVGVVITLVLVGRLLEAKAREGTGKAVQSLIRLRPRTAHKLNATSADNVDGIEWRNPAHFTDTDIDAIVTGDLLIVKNGERVPTDGVIVAGEARIDESMITGESKPVSKTAGDPVTGATVLLKGGCVMRATQVGADTVLSQIAAMVARAQATKAPVQQLADKIARYFVPAVMIIAIWTFAIWRSLGPAPQLAHALVTAVSVLIIACPCALGLATPLSVTVSLGLGATNGVLATSAKALEQARRIGTVVFDKTGTITRGVVDAAADWDKPSYEQDTVKEGSREAVAALRARGIRTVMLSGDKAEVAGRIAREVGIDTVICEVKPDGKAYWIAKLQRERDEAAAKSAYGTSRTAAQSRTLIAMVGDGINDAPALAQADLGIAIGTGTDVAMQSADVTLMSGDLRGVIKTINLSNATMRNIRENLGWAFGYNVIGIPVAAGVLYPFTGWLLSPMIAGLAMALSSVCLVLNANRLHGANINVGAADGPAGSGSSTADVESAGSAESANAANITGSATSNAPHEPTVIIDDRTTLNQTNHVSDQSNNPTNKENTMDMGMHMHHTAPADGETATDPVCGMTVAVNADAITREYEGKSYYFCGEHCATNFMKAPQVFLEQ
>NZ_CP034089.1|WP_013410393.1|286942_287677_+|aquaporin-family-protein
MDYPLFTKLAAEFFGTAILMIFGNGSVANVELKNTKGHHAGWLNIAMGYGFGVMFPVLMFGSVSGAHINPAMTIAQAVNGLFPWSDVLPYIVAQLLGALLGQLIVYITYYPHYKETEDAEAILGTFCTTDADNQKANYFLNEMFGTLVLVFGALCCLSLAWGKQDYAAASIVVGFIVWGLVTSMGGPTGPGLNPARDLMPRLLHAILPIPHKGSSRWGEAWIPVVAPIVGAIIGAWLFVFFFAS
>NZ_CP034089.1|WP_155661277.1|285029_286709_+|phosphoenolpyruvate--protein-phosphotransferase
MRTIQGVGVSAGIAIGTVRVLAAVDYAVERRVIDDPQAEMDRFRAARDTAVAQLKQLRDNVAAEFGENKAELFDAHRLMLQDPDYAECVEGLIAQDKVNAEFAVKSVAEQFAAMFAAMDSSTMQARAADVKDVSRRVMNVLQGKCDSAAQDGSVQGDAVQNGIVQNGIAQNGESHIIFAEDLAPSETAQLDRAKVLGLVTAKGSANSHTAILARTMGLPAITGIGDAFDPADDGHVAVIDGASGAVFVDPDEAALTEYRRRKAEAEEHLSLLRKLKGKPTETKSGQRVHLYANISRPSDAAAVLANDAEGIGLFRSEFLYLEREDWPTEEFQFDAYGQVAQEMGDRPVIIRTLDIGADKQVDYFNLGHEDNPALGYRAIRICLTRPEIFKVQLRALLRASAYGNIAIMLPMITSVQEVRDAKRILEEAKSELRGERIDFNESIQIGVMIETPASVIMADELAAEVDFFSIGTNDLTQYTLACDRQNPSLERFADPHSPAVLRMIQMTIEAAHRHGIWCGICGELGADLSLTDTFLRLGIDELSVSPTSVLPLRNVIRNH
>NZ_CP034089.1|WP_011068472.1|297755_298793_+|GNAT-family-N-acetyltransferase
MATEAQLKRDLPQSIVIPPIRGEMVHLRPATVEDLPRLDELDAFYGASKITGKDAVTERAIVHTWVRRSQAWEAGQAPAESGVGDPESRRTIAWAVLTDADHDDDGQLDAASTDNVIGMIFLIDIDGWSKSARIQIILGREYRGRGYSRDAMPRVMTYGFAPEPAGLGMHRIWVSVPEKNSRSISVYQSLGFVPSGTSRDALWDAENNKYQDLIVMDTLADEYDPIRSLDAFGMHLIEDNPGVKEALSAREHSIAIQQNKPEPEPAQRGEAAGATTSDVQSQAQTPAAAQPVEPQAEHHDDTQKNTRHSLEEESNWPYGQAERKPSKEAWWRTLGRGRKRDTESE
>NZ_CP034089.1|WP_003828150.1|298803_299118_+|DUF2469-domain-containing-protein
MSAEDLDNYETDAELALYREYRDVIKLFTYVVETERRFYLANKVDFNVRSAGQDVYFDVQLTDAWVWDVYRSSRFVKSVRIVTFKDVNVEEVQKTDIDIPDDIH
>NZ_CP034089.1|WP_011068470.1|299324_301145_+|histidine-type-phosphatase
MVAAATLLAGGILTVPHAMALEADGQYYSSKQPYVAPSEATTASYSQAPEGYETVYTESMARHGSRGLSSYKYDALLMKMAEAAEADNGFKSDAIKSEFMKNLKAITAANVENGYGMLTGQGADQHQGIGARAYERNKTLFDNAAKDGGKIAYQSSGEARATESGENFARGFNAASNNKLANSTVTPADPAGTGEAAAFDKTPNTLYFHKSENPDGTEKTGEAKQRADDYQNFVENDAIIAGAEQTIAENEDVKTASHDLLSQIFTDDFLAKLADGTYAWYNTVDGTKGGEANCAPGADPSKDADACGAAKKKIASEYDAAMDLYNLYIIAADMENENTGSHTFDFNQYFQGEQADDAKLFAWALDAEDFYEKGPSYAGQDETYTIAQPLLDDFFSSIDERVNGGSTVATFRFAHAETMMPFAALLGLPGSTQQAAASTTDVYTYANNEWRGESVTPMAANVQWDVAVKSGNDPKTGRAYTPLVRMLYNEQEIAFRSECTPIADGSTWYKLTELKSCLASDHQTLGDDAHLTDDSTTQPGTGPNTGEGTSTTPNNNGAGTHQPSNTQANGTENELSRTGVAVTGVAGIMMLLALAGISLNLWKVRR
>NZ_CP034089.1|WP_007051527.1|301363_302977_+|NAD(P)/FAD-dependent-oxidoreductase
MTDKQSVVIIGGGPAGLTAAWELIKDGGADKYDVTVLEGTREFGGISRTVKHNGNRMDIGGHRFFSKDERIMDWWKTVLPLQGAPSYDDKKLGRDHDMEPGGPDPETEDKVMLKRHRVSRIFWNRHFFDYPISLSPNTLKAMGFKLTMVAGFSYLKSMFHKLPEDNLENFYINRFGRKLYSMFFEGYTEKLWGRHPSQISADWGAQRVKGLSIMGVLKNAFQKLLPKKRSNAEVETSLIEEFWYPKYGPGQLWETVESNCEAAGVKVLTDARVVEVRQTDGAVSSVVYEDSEGNRTELSGDQFISSMPVKDLVNAIDAAGADPEAVDSKPAPADMTEVANGLPYRDFVTVGLLVKHLKLKNTTSIPTLGNPPIVPDCWIYVQDPGYKVGRLQIFNNWSPYLVKDVDDTVWIGLEYFCEEGDSFWNMSEEDVTKFAISELTRMRVINGPDEVIDSHRERVRKAYPAYFDTYEHMDELIEYLDGFGNLYCVGRNGQHRYNNMDHSMATAMEAVGNIKTGKTSKKNVWSVNTEKSYHEEK
>NZ_CP034089.1|WP_007056503.1|303182_305252_+|transcription-termination-factor-Rho
MANSQNLEDMKLPELKELAKQMGLRGTSTMRKPELLATLQAARNGGEPPAGVTVRAPKAAKTAKVVKAPQSDAAEANTTDNADVATQSPAPAPAATEPQLDLPLPVADDAKKDETEPRRTRRKAADDAASEPRAARRRRDDDQPDFARRKPRKKADEAGDLLATLDLGDAAPTERRRERHEDVEVPLIRRVRDDEDEQPRRRRRTAENSEETVRDLDDILATLPTQKHEETSEDGEQNDDHEFVRRNRRDRSDRNDRDTRNDRSDRRNRRMRGRDRDNADDDRRYDDRDNRSDRNDRDSRREEPQEDLVPVAGIVDVLDSYAFVRTSGYLPGPNDVYVSMGQVKKYGLRKGDAVHGSIRAPREGDRRNQRQKFVPLQAIDSINGQSVEEALNRPQFSKLTPLYPQERLKQETAPNKLTGRIMDIVSPIGKGQRGLIVSPPKAGKTITLQNIANSIAANNPEVHLMVVLVDERPEEVTDMERTVQGEVISSTFDRPASDHTTVAELAVERAKRLVELGQDVVVLLDSMTRLARAYNIAAPASGRILSGGVDAQALYPPKKFFGAARNIENGGSLTIISSALVETGSKMDEVIFEEFKGTGNMELRLSRELADKRLFPAIDINASGTRREELITNPQELPIIYRLRRLLGGMEPEQAYQTLVPRLKKTATNRDFLAAIVQQANTGNAVNGN
>NZ_CP034089.1|WP_007051524.1|305559_305949_+|chorismate-mutase
MSETSSDWQRTTIDSAQAAAHPETAQAVARIKALRQTIDNIDSAVIALLAERFKATSQVGVLKANAGFAPEDTKREDYQIERLHRIAIDAGLDPEIAEMYREFVVTEAKKRHQRIADAGGDPGVLDVFA
>NZ_CP034089.1|WP_007056480.1|306070_308155_+|hypothetical-protein
MRCGAALVSCALCVASILGGAWMSRPTPVDYGPVLATASDMYAVTDAEGEPVRWYVVGKGGAGNGASADSGNSGSTDTDSANSNSGTSKVSRIPASAATLPWKVSVTYSLDGPNVEANEVAGASGLIGVYIDIKPQTKEANRTIPVVAFTVPTQVADDVSADNSITVTTQGSNTVVAAAGKAATGLEFSCYMNAKDFSMSSVALAVLPSNSSSPAVGANPDAANAANAAAQPAADTDVAQLTASAATLVDSLTDAGSGEQQQLIEQLQTLRDNERALNKSVVAERETAHKRTFEDYMAAYVGSYTTHLSGSIGTSTQLPALMGTAGELSGDTPLAQAVLDLANAVNNVSAAHQHAGAVDALDEVIRRIQQQGTTGLVDDLIAEASEEATQGSKQYADGQSQLSAAMIPYSMKYTDVYTANLSALTGGTSSGATAYESQAIAETNGSDELADAQSKVDAAMSTLATASEHTGKATALRQIVLRFSDQFEGGASSASGSDGDGSSGDVSSDPVTEAQALTGLVDSQSQSFYGKTRVAQAKRKADAARKQAKAAQQQQSQHSKASLVDDTMSMSAGDVMNYAGGLTSAIGGGDKSDSSKSAGSGTNDSAKSSDTGDSGNGKASDASDSGNNLDTAPVLFGFGTGGTLFKHDMNALINETVKISDAGTLLAQAVAQLDSPNTQQKTAETRYLIVIPTV
>NZ_CP034089.1|WP_011068468.1|308380_311221_-|valine--tRNA-ligase
MAHYRSIVRTSPANSLLGCLLYSSACHATCINFGLMTEGKSIINANLTPLPDKVGVDGLEDKWRTVWDEDGTYKFRNTRDRKAVYSIDTPPPTVSGSLHVGHVFSYTHTDVIARYKRMRGYDVFYPMGWDDNGLPTERRVQNYYGVRVDVSLPYDPDFKPPFEGTDGKKIDAKDQVPISRKNFIELCERLTAQDEKLFEALWRKLGLSIDWSQTYHTIGQHPQRVAQKAFLRNLARGEAYQQDAPGLWDVTFQTAVAQAELESREYPGFYHKVAFRFEDGTPIYIETTRPELLAACTSLIANPNDERYKQYFGQYVYSPLFKVKVPILAHPAAEMDKGAGIAMCCTFGDVTDVEWWRDLKLPTRPIIQRNGRIVMDTPDWIEDPAGREVFAETAGKTTFSARKIIVDKLRESGDLDGEPTPTKRMTNFYEKGDKPLEIVTSRQWYLKNGGTDAKLNAELIERGKELEFHPDFMRVRYENWVHGLNGDWLISRQRFFGVPFPLWYPVNASGEPDYDHPITPSEDRLPIDPTIDVPEGYDESQRDVPGGFTAEKDIMDTWATSSLTPQIVTHWAEPDEASKALFASTFPMDLRPQGQDIIRTWLFSTVDRAHLENKCLPWAHATLSGWILDPDHKKMSKSKGNVVVPNEPIEKFGADAVRYWAAAARLGLDATYDIGQMKIGRRLAIKLLNATKFALAIGREDENHHVGAAAEAAWNPADVTEPLDRAAMAKLALVVRQATEALESYEHSKALEVIESYFWQFCDDYIELVKNRAYGTPDEHGNVPSEKAVKSARTALGLGLDAFARLLAPYLPYATEEVWSWMHAGSGSVHRAAWPVVDPYVEAATGASPELLTWAGKAVEQLRKIKSEAKVSMKTPILSVALSAASEGVEAIHAALGDIAQAGRVVGKFDLVAKHAEESAAEGTPETEVAVEASELGEPPAKKPKH
>NZ_CP034089.1|WP_155661479.1|311259_312726_-|ABC-transporter-substrate-binding-protein
MALGALVVVGWTFMQNRFQPGSSLDADVTIGIDDMPQSLDIRSDSSAAAERLLVDNVYETLVTVDQDNKLQPGLATSWKTSDDGLTVTLTLQSGVTFSNGHTLDASDAVWSLQQNVTNKVADVDELGDLASVANPNATTVVITLAKPNPTLLRALSGRLGIVYDSESSSADYQRKAIGSGPFTVADFQSGHSLKLARSDTYHGTKAASNVVEFMQYSDADALSKALTDGSLDMAAPVSASTATGLNGKDGLTVKEGATTDKVLLAYNNGTDSLLSDEQARKAFRYQIDAAGIASAQPDAAGALGGPISLLEPGYEDLTGLYPHDENQAGQMFSYFGAQYLTTVNLVVPEEYRSLAETIKQQIERQPRPTVNLEVLSDEDYAKRIKDGKWELTVMSMDGTDDAGIFADPDSMFHYDHTEAQQAYADARAATNDADYEARMKAYARLISEDAASDWLYTRKCFTVASTKVSGYPTSMINRRMPLAGLTVK
>NZ_CP034089.1|WP_007051520.1|312847_313534_-|endonuclease-III
MRETKSARLTRMHDEYDILRQVIPAPACALHFSNPLELLIATVLSAQTTDKRVNTVTPELFATYPTARDLAAANPAQVEDIIHPLGFYRSKTQHLIGLATALDERFGGVVPRTMDELTSLPGVGRKTANVVLGNAFDIPGFPVDTHVMRVTGRLRWRSDWRSAHPDPVKIEKEITSCFPPEEWTNLSHRLILFGRATCHARTPDCANCPLSDTCPSYAPPAGKSTSKR

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP034089_2

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP034089_2

841614-841688

Orphan

Consensus_repeat	Method
TAGAGGTGTCAAAATGACACCTCT	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP034089_2

>merge|NZ_CP034089|2|841614-841688|CRISPRCasFinder
TAGAGGTGTCAAAATGACACCTCTGGAAAACGGCGGAAACAAGCCAAAATCTAGGGGTGTCAAAATGACACCTCT

>NZ_CP034089|2|2|841614-841688|CRISPRCasFinder
TAGAGGTGTCAAAATGACACCTCT	GGAAAACGGCGGAAACAAGCCAAAATC
TAGGGGTGTCAAAATGACACCTCT

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP034089.1\|WP_118088631.1\|840335_840806_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_155661323.1\|838177_839359_+\|DUF2637-domain-containing-protein	unknown	unknown	gnl\|CDD\|378511
NZ_CP034089.1\|WP_011068238.1\|833989_834751_-\|NUDIX-hydrolase	unknown	unknown	gnl\|CDD\|239516
NZ_CP034089.1\|WP_117778126.1\|835638_836064_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_131207926.1\|843788_844208_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_155661327.1\|845851_846142_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_007057039.1\|840831_841050_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_155661324.1\|839361_840339_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_007057041.1\|846671_846857_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_007051936.1\|844309_844795_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_155661485.1\|836139_836643_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_155661484.1\|834826_835324_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|285830
NZ_CP034089.1\|WP_077385634.1\|846138_846675_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_060868164.1\|842753_843626_-\|GNAT-family-N-acetyltransferase	unknown	unknown	gnl\|CDD\|366181
NZ_CP034089.1\|WP_155661328.1\|846853_847342_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_155661322.1\|836903_838127_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|379172
NZ_CP034089.1\|WP_007051942.1\|848330_848864_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_007055467.1\|832399_833842_+\|pyruvate-kinase	unknown	unknown	gnl\|CDD\|223545
NZ_CP034089.1\|WP_155661326.1\|845456_845855_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_100969586.1\|847363_848344_-\|nucleotidyl-transferase-AbiEii/AbiGii-toxin-family-protein	unknown	unknown	gnl\|CDD\|378065

Protein	Function_ID	Function_description	E-value
NZ_CP034089.1\|WP_155661323.1\|838177_839359_+\|DUF2637-domain-containing-protein	gnl\|CDD\|378511	pfam10935, DUF2637, Protein of unknown function (DUF2637). This family of proteins has no known function.	1.69985e-07
NZ_CP034089.1\|WP_011068238.1\|833989_834751_-\|NUDIX-hydrolase	gnl\|CDD\|239516	cd03424, ADPRase_NUDT5, ADP-ribose pyrophosphatase (ADPRase) catalyzes the hydrolysis of ADP-ribose and a variety of additional ADP-sugar conjugates to AMP and ribose-5-phosphate. Like other members of the Nudix hydrolase superfamily, it requires a divalent cation, such as Mg2+, for its activity. It also contains a highly conserved 23-residue Nudix motif (GX5EX7REUXEEXGU, where U = I, L or V) which functions as a metal binding site/catalytic site. In addition to the Nudix motif, there are additional conserved amino acid residues, distal from the signature sequence, that correlate with substrate specificity. In humans, there are four distinct ADPRase activities, three putative cytosolic enzymes (ADPRase-I, -II, and -Mn) and a single mitochondrial enzyme (ADPRase-m). Human ADPRase-II is also referred to as NUDT5. It lacks the N-terminal target sequence unique to mitochondrial ADPRase. The different cytosolic types are distinguished by their specificities for substrate and specific requirement for metal ions. NUDT5 forms a homodimer.	1.48532e-43
NZ_CP034089.1\|WP_060868164.1\|842753_843626_-\|GNAT-family-N-acetyltransferase	gnl\|CDD\|366181	pfam00583, Acetyltransf_1, Acetyltransferase (GNAT) family. This family contains proteins with N-acetyltransferase functions such as Elp3-related proteins.	0.000119891
NZ_CP034089.1\|WP_155661484.1\|834826_835324_-\|hypothetical-protein	gnl\|CDD\|285830	pfam08667, BetR, BetR domain. This family includes an N-terminal helix-turn-helix domain.	6.45257e-05
NZ_CP034089.1\|WP_155661322.1\|836903_838127_+\|hypothetical-protein	gnl\|CDD\|379172	pfam13412, HTH_24, Winged helix-turn-helix DNA-binding.	0.00484618
NZ_CP034089.1\|WP_007055467.1\|832399_833842_+\|pyruvate-kinase	gnl\|CDD\|223545	COG0469, PykF, Pyruvate kinase [Carbohydrate transport and metabolism].	0
NZ_CP034089.1\|WP_100969586.1\|847363_848344_-\|nucleotidyl-transferase-AbiEii/AbiGii-toxin-family-protein	gnl\|CDD\|378065	pfam08843, AbiEii, Nucleotidyl transferase AbiEii toxin, Type IV TA system. This family was recently identified as belonging to the nucleotidyltransferase superfamily. AbiEii is the cognate toxin of the type IV toxin-antitoxin 'innate immunity' bacterial abortive infection (Abi) system that protects bacteria from the spread of a phage infection. The Abi system is activated upon infection with phage to abort the cell thus preventing the spread of phage through viral replication. There are some 20 or more Abis, and they are predominantly plasmid-encoded lactococcal systems. TA, toxin-antitoxin, systems on plasmids function by killing cells that lose the plasmid upon division. AbiE phage resistance systems function as novel Type IV TAs and are widespread in bacteria and archaea. The cognate antitoxin is pfam13338.	3.46344e-28

>NZ_CP034089.1|WP_007057039.1|840831_841050_+|hypothetical-protein
MRIIIDGHGRIDRQAMAVERLKTIDMTPAGGGDAQDWVGAWLDGFDQALDLCRALETALDADTGKELSGDAR
>NZ_CP034089.1|WP_118088631.1|840335_840806_+|hypothetical-protein
MITMMSAPAGAEPDAVTLQIPAIPMTWEQASIMLDATFDAWRMLSGEIDAARGDDWQWIQEILALPAHTRYIKAAGDEAMVCSAAMRETWPGRWHDLLRARVQDVIDALVSHEREIRAMDPGMFARMPSPSLCDRVRKRHDPTRMTLGMTVQELAR
>NZ_CP034089.1|WP_155661324.1|839361_840339_+|hypothetical-protein
MRESDEPLTDTLVRCLADPMDLKALERLENDGDQAGARLMRARLADQAALRLDAALEDNRARVRRQLGRDWAWATDEVMSDLTIRTIRRLDYWHRTNTDRAEGGATSLAAFVNQLTGTVVGEWFKTQRPKHRTGMTQTPERRAGRLKPPTDPDDRTAWERWRRHEQTLADSDVICDASDIFEGRDGDGESPGSPASGDRESYRQWGGDTADAPLPVSAGYKTDMEALALAVQAEWGLAAWKRILTRCMTSNRARPLLREIRHWLEAHHNGTTPRLDRYPYLRACAGTGARNRPKTGDGRVKEQTKGQREAGRRGPRTIEERKERP
>NZ_CP034089.1|WP_155661323.1|838177_839359_+|DUF2637-domain-containing-protein
MNDKKTKEVDGRESVSMLPGVTVGVMIAVIAFVLSFDALRLVFVSSGINPLLSWGGPLCVDGTILLCTWATWGFRKGHIRGRWYPWAGLVLFSLFSVTGNALHAWLNAGGMLPTWGAPAIMSIPPIALLYSTHLIVIIAGDRQDKLARTTGKAAGPDDGHAGPAAATPETAGTEPVRTENPRAIPTPTAGPEPGKATEPAPADPLDRYLFDPPAQAEADANRGKKEGPEDIPFDQDLSWPSVTSATTTSARATESTIHMVRMDQAHADQDLADQDRMGRKPEMDPKGQPGPEAGGHAGHAEPEPAESHEGAMSGPDRSSDTGSAHDAGPKAGEPARKATAGFDPDEWLAWADRLKANGETVTSTRAVADGLASSTTTAKRRLHTLRREHPGRF
>NZ_CP034089.1|WP_155661322.1|836903_838127_+|hypothetical-protein
MTNSYINPTQPTASEPRYSQNEPAWQDVEIVDVPAVEEPEPAEGAPEPIRIIDEPEPGEATAGDAVIEYTRDHLPVNMGVDTDQSDFTREQAEQLVGDIQEQFYETAKSQKRLHDLIAQAYDGRAWIALGYPAGLIGWNQLCQDRFTADAVRMTVQQRTNLILSFQDDPISNRSLAAALGVSEGTVRKAVKKAKGASAKPKPVVGADGKRHSVPELTPAERLELDAKIHDMNLPVEEGGQGMTQQEIAAKLDMAQSTICASIKRETMRRMSEGLEPAAPAPVDETGAIGVLPDNTAIDLGGDRLAADDMNFVEAFRTAAGDANAGLTRLVELMSSERWQPGSETVDEIVTRAGRDIKGVLANVGPFMRLVDHDLEDMWPADENDRSRDQDEVNGLFDQILTVASECA
>NZ_CP034089.1|WP_155661485.1|836139_836643_-|hypothetical-protein
MGRTDIVSKHNRSAGMMEDNTDAGFSPILRRRLMTVDRISGFLQGASIPLRLHVSPIMTVRAALRYEALARDETVLARRARLAWLAYRMAVADGLFRNVTDPAVMDGLRWMLSTGITDGELFDAGLSSGIVLAAATCDDAYGFVHDVASAVAEGRRSAVAAVGRTRL
>NZ_CP034089.1|WP_117778126.1|835638_836064_+|hypothetical-protein
MSERVLWLRLCVTGPTPECGEIVGLRIVDRQAHRTVFDAFFHPVREDGWKSVPAGGVNVNLANRLPLNIYVDGIEWILSGATLLRGEHVARDVRFLRAAGVHLEDQVVARSVAAERHKRLASGIAVPTRTGNRACRPIPVG
>NZ_CP034089.1|WP_155661484.1|834826_835324_-|hypothetical-protein
MSTSPMNKETEITDNGLPKVLSQIITDNVYFLKQRHRVPQTSIANAMHITQSTLNLKLGGKVRWNVDDLAYLSAFFNVSVAYLVTNNVTMPSDHYQLRTQYAADNAIPSQELAGAAGPRYIVRPDDGAENTKKRGANNSPRAIVMPYDPDFWVPSVGLEPTLRRF
>NZ_CP034089.1|WP_011068238.1|833989_834751_-|NUDIX-hydrolase
MRHKTRANPPFPPVKQAKHVDIADGAPVCCPFSCVVSPLTMGCSFDVSLLLGGLMSNETYRQFDPWRPSPVKEISRRQIVETHYFNVDHVSYESNQIGSFERYFVQENNGDTVAVLAVTDDGMIPLVEQYRIANHRWTLEIPAGHANNPSERPTDVAKRKLAEEAGFDATKLTQFTRFMNTPSYSTQHTAIFFATGLTPASRQEIGPETPRSDVRMVSVDDAYEMVVNGTIVDAKTMVAILRLKSGTLDHLND
>NZ_CP034089.1|WP_007055467.1|832399_833842_+|pyruvate-kinase
MRKAKIVDTIGPSTEDYDNLLKLVEAGMDVARLNRSHGTPEDHLKVYNNVRKASEATGRNVAALVDLQGPKIRCGWFKKNADGEDKVQLQLGQEFVITTDDVEGDEHITSTTFKGLPGDCHPGDPILIDDGKVRLEVTKVEGNNVYTKVVVAGPVSSHKGINLPGVAVSLPALTEKDEADLRWAIRTGADIIAMSFVRFATDIDRAHEIMDEEGRRIPIIAKIEKPQALENLEEIVKTFDGVMAARGDMAVECPLEEVPLATKRIIELARQYAKPVIVATEVLGSMVNSPVPTRAEASDCANAILDGSDATMTSNETAVGKYPDVTVATMARISGYATDHGFDRIPELKNLDMSSTGAVSSAAVDLADKLNAKAIVAYTQTGATVHRVSRERPAAPIYGLTSNEHTYHWLALSWGTEAFLLKEDYHDKSRKDLMVYTDKVLKDAGKVADGDKIVILSSAQGDHQPGRTDSIYVHTVGACD
>NZ_CP034089.1|WP_060868164.1|842753_843626_-|GNAT-family-N-acetyltransferase
MTVGIVLLPISGRWRIIGIMKDGINQCGGSGIESVDHFDGVGIVRIRPVVNKVEIKRAKRLIVEQIPHLADIEFPKRPVEDDGTLRPLFIGAFSKDGLIGAAFVTPGIQAAQSFLGYFSASAGAYQCAELVRRTVAEVEGIAVVDEYRRRGVALALKRYIDAWAADHGACLVLSVPTNEAARGLNEKSGHRVLEPDVLLMLQVVYADGGPCSLPFALERGQEAGYSCWAFLPIAKPGGMSVRAGQCPSVASSPGVSGEEYFAVKWETRDGDGNWIATTSRLRGVRADVMD
>NZ_CP034089.1|WP_131207926.1|843788_844208_+|hypothetical-protein
MKVILFVTIIVLGGLSLATWLCMHLEDHLEWREWHVPRGTEFISYPLEYGEHDGLLLTDVEYATCKDLLEVRYTVENRNKGQTPVRNDLILAFQNGIGLRTVSPTTWTVMLEGAHARMTQSFRLRDRATRPVIQPDRTW
>NZ_CP034089.1|WP_007051936.1|844309_844795_-|hypothetical-protein
MTRAREWQVSLDFKARLDEDAAFDLMEALGRYGASVAVDPGHTGGGLTLAVDAPDGETALDKALTLLEKNMPGATVTGLEAREWADAVARNREPLYPPVVGYAEIARMTGVTRQRAYAFPRIESFPKPVIETSQGPLYSEDAVRAWAQTRELRPGRPKAME
>NZ_CP034089.1|WP_155661326.1|845456_845855_+|hypothetical-protein
MGMTGFSDAEMALLSGLDAVAWVTRTRITYTDSFKRDAVTRYRRGESPVRIFREAGLDPRIIGNKRIERCIARWKREPPDAGTTRPHAPAPDAGREGRPAPMSVVLAQTMRINALEERLRRLELSLADGTTR
>NZ_CP034089.1|WP_155661327.1|845851_846142_+|hypothetical-protein
MSAGPANPVDRLEQAAKQFKDSGVIQLAVQGLLLEGVARDLRRCDAATVGCVELSAWLNRGIRELERRKRIVDAQITLIGTRHGEYTRYTKYGRNL
>NZ_CP034089.1|WP_077385634.1|846138_846675_+|hypothetical-protein
MNNDTGGDHPMPGTRMRRLFDENLSMIETMTRIEIRRLGRMPRGTHLGQDDGNPVTDLLPDRYLDRYDREFLYRMLGSTIRLRARLADPKTDHAAHSVIEEILISRAVRLVADDDNEEGSGLEAWLEDWLGDLDVDRLYDPAADEATLASDPATGSGDMRFDHWFEDQYWADETDGGE
>NZ_CP034089.1|WP_007057041.1|846671_846857_+|hypothetical-protein
MMDDERRKAILLALACLAILILLIIECAIMPRMGWLWIITAALDLVLLAMCVRHIIRGGRK
>NZ_CP034089.1|WP_155661328.1|846853_847342_+|hypothetical-protein
MNPVTGAVPPLIRGHGIRFEVDRWAWRRLDAARFDGERRHLLATRGRPWHADPRHGGDTDALETWHLLAGRHQGGGMGLTVTGPGGKLDVSWEPDGAIPPDGRFYPNPDPSAAYPLLELERAGIIRPVEPAITAYGPYGRPTRLMEVTEPYHNPMLRALRMR
>NZ_CP034089.1|WP_100969586.1|847363_848344_-|nucleotidyl-transferase-AbiEii/AbiGii-toxin-family-protein
MDGSDMAFDYKAVAAGIARSEGMGALLPVVEKELLHYRILSAMQDGGFFGPIVFQGGTSLRLCHGSPRYSEDLDFAGGTGFGVDDLRGLGECVRSSLAGMSPDVQVKVREPVRDEGLVRRWRISIRTAAQRRDLPSQSIKLEVASVPAHEPQTRPVRVNYPSVSAIAGDIILAVESPTEILADKLLSFACSSHIRRRDLWDMCWLSSRADVDASRAFRMATLKAGEYGEVGEWEARAGRLREIPSVLSSDAFLDEMRRFLPARMLVATVESLSWREYASQAVTGLYDPSGPAWASPYGSPGFGRPMPEPDQSSAVPMWRDGGPALS
>NZ_CP034089.1|WP_007051942.1|848330_848864_-|hypothetical-protein
MNRLRDMDTGFGVHVYRKPDLALVLGETGQRLDRTLSSLVAANVLVRAARGVYAFAWSAHLGEATLHTVARRLRPRQLVWESLESALSRWGVISQIPVDRVTFMTTGREGLAVTPYGTIEFTHCALDWSRILPNLVPRDGGMTPLASKRWAYRDLKATGRNLDLVDMDELENDDGWE

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP034089_3

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP034089_3

2030699-2030784

Orphan

Consensus_repeat	Method
GGCCCTGAGCGTGCGGGCGCGGA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP034089_3

>merge|NZ_CP034089|3|2030699-2030784|CRISPRCasFinder
GGCCCTGAGCGTGCGGGCGCGGAATCGCATTTGAAGCGGCATTGCCGCCATTGGCACCGGCGCCGCCCTGAGCGTGCGGGCGCGGA

>NZ_CP034089|3|3|2030699-2030784|CRISPRCasFinder
GGCCCTGAGCGTGCGGGCGCGGA	ATCGCATTTGAAGCGGCATTGCCGCCATTGGCACCGGCGC
CGCCCTGAGCGTGCGGGCGCGGA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP034089.1\|WP_013410645.1\|2033633_2034677_-\|LacI-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|224525
NZ_CP034089.1\|WP_007052308.1\|2027768_2028242_-\|30S-ribosome-binding-factor-RbfA	unknown	unknown	gnl\|CDD\|234787
NZ_CP034089.1\|WP_003829907.1\|2043707_2044106_-\|30S-ribosomal-protein-S11	unknown	unknown	gnl\|CDD\|180007
NZ_CP034089.1\|WP_131206623.1\|2026603_2027767_-\|tRNA-pseudouridine(55)-synthase-TruB	unknown	unknown	gnl\|CDD\|235113
NZ_CP034089.1\|WP_131309130.1\|2018594_2020229_+\|pyridine-nucleotide-disulfide-oxidoreductase	unknown	unknown	gnl\|CDD\|235798
NZ_CP034089.1\|WP_007053048.1\|2042631_2043627_-\|DNA-directed-RNA-polymerase-subunit-alpha	unknown	unknown	gnl\|CDD\|235359
NZ_CP034089.1\|WP_007055304.1\|2037587_2038388_-\|transglutaminase-family-protein	unknown	unknown	gnl\|CDD\|224224
NZ_CP034089.1\|WP_011068749.1\|2023068_2023647_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_081049871.1\|2032771_2033593_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_007052314.1\|2021936_2022635_+\|ribose-5-phosphate-isomerase-RpiA	unknown	unknown	gnl\|CDD\|234816
NZ_CP034089.1\|WP_008782965.1\|2031589_2032657_-\|transcription-termination/antitermination-protein-NusA	unknown	unknown	gnl\|CDD\|237061
NZ_CP034089.1\|WP_011068752.1\|2020415_2020763_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_155661443.1\|2038594_2040775_-\|UDP-N-acetylmuramate-dehydrogenase	unknown	unknown	gnl\|CDD\|379601
NZ_CP034089.1\|WP_007053050.1\|2040996_2041908_+\|tRNA-pseudouridine(38-40)-synthase-TruA	unknown	unknown	gnl\|CDD\|211337
NZ_CP034089.1\|WP_155661442.1\|2020765_2021806_+\|ribonuclease-HI	unknown	unknown	gnl\|CDD\|260010
NZ_CP034089.1\|WP_007055364.1\|2025381_2026506_-\|FAD-synthase	unknown	unknown	gnl\|CDD\|235536
NZ_CP034089.1\|WP_004268639.1\|2022787_2022877_-\|AURKAIP1/COX24-domain-containing-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_008783615.1\|2035209_2036778_-\|alpha-N-arabinofuranosidase	unknown	unknown	gnl\|CDD\|226064
NZ_CP034089.1\|WP_007055359.1\|2023828_2025367_+\|DNA-repair-protein-RadA	unknown	unknown	gnl\|CDD\|236994
NZ_CP034089.1\|WP_117768520.1\|2041989_2042532_-\|50S-ribosomal-protein-L17	unknown	unknown	gnl\|CDD\|235522

Protein	Function_ID	Function_description	E-value
NZ_CP034089.1\|WP_013410645.1\|2033633_2034677_-\|LacI-family-transcriptional-regulator	gnl\|CDD\|224525	COG1609, PurR, Transcriptional regulators [Transcription].	1.19653e-80
NZ_CP034089.1\|WP_007052308.1\|2027768_2028242_-\|30S-ribosome-binding-factor-RbfA	gnl\|CDD\|234787	PRK00521, rbfA, 30S ribosome-binding factor RbfA.	1.2318e-44
NZ_CP034089.1\|WP_003829907.1\|2043707_2044106_-\|30S-ribosomal-protein-S11	gnl\|CDD\|180007	PRK05309, PRK05309, 30S ribosomal protein S11; Validated.	1.00735e-79
NZ_CP034089.1\|WP_131206623.1\|2026603_2027767_-\|tRNA-pseudouridine(55)-synthase-TruB	gnl\|CDD\|235113	PRK03287, truB, tRNA pseudouridine synthase B; Provisional.	2.63323e-102
NZ_CP034089.1\|WP_131309130.1\|2018594_2020229_+\|pyridine-nucleotide-disulfide-oxidoreductase	gnl\|CDD\|235798	PRK06416, PRK06416, dihydrolipoamide dehydrogenase; Reviewed.	2.0969e-81
NZ_CP034089.1\|WP_007053048.1\|2042631_2043627_-\|DNA-directed-RNA-polymerase-subunit-alpha	gnl\|CDD\|235359	PRK05182, PRK05182, DNA-directed RNA polymerase subunit alpha; Provisional.	0
NZ_CP034089.1\|WP_007055304.1\|2037587_2038388_-\|transglutaminase-family-protein	gnl\|CDD\|224224	COG1305, COG1305, Transglutaminase-like enzymes, putative cysteine proteases [Amino acid transport and metabolism].	3.46877e-29
NZ_CP034089.1\|WP_155661443.1\|2038594_2040775_-\|UDP-N-acetylmuramate-dehydrogenase	gnl\|CDD\|379601	pfam14403, CP_ATPgrasp_2, Circularly permuted ATP-grasp type 2. Circularly permuted ATP-grasp prototyped by Roseiflexus RoseRS_2616 that is associated in gene neighborhoods with a GCS2-like COOH-NH2 ligase, alpha/beta hydrolase fold peptidase, GAT-II -like amidohydrolase, and M20 peptidase. Members of this family are predicted to be involved in the biosynthesis of small peptides.	0
NZ_CP034089.1\|WP_007052314.1\|2021936_2022635_+\|ribose-5-phosphate-isomerase-RpiA	gnl\|CDD\|234816	PRK00702, PRK00702, ribose-5-phosphate isomerase RpiA.	3.30832e-120
NZ_CP034089.1\|WP_008782965.1\|2031589_2032657_-\|transcription-termination/antitermination-protein-NusA	gnl\|CDD\|237061	PRK12327, nusA, transcription elongation factor NusA; Provisional.	4.73186e-149
NZ_CP034089.1\|WP_007055359.1\|2023828_2025367_+\|DNA-repair-protein-RadA	gnl\|CDD\|236994	PRK11823, PRK11823, DNA repair protein RadA; Provisional.	0
NZ_CP034089.1\|WP_007053050.1\|2040996_2041908_+\|tRNA-pseudouridine(38-40)-synthase-TruA	gnl\|CDD\|211337	cd02570, PseudoU_synth_EcTruA, Eukaryotic and bacterial pseudouridine synthases similar to E. coli TruA. This group consists of eukaryotic and bacterial pseudouridine synthases similar to E. coli TruA, Pseudomonas aeruginosa truA and human pseudouridine synthase-like 1 (PUSL1). Pseudouridine synthases catalyze the isomerization of specific uridines in an RNA molecule to pseudouridines (5-ribosyluracil, psi). No cofactors are required. E. coli TruA makes psi38/39 and/or 40 in tRNA. psi38 and psi39 in tRNAs are highly phylogenetically conserved. P. aeruginosa truA is required for induction of type III secretory genes and may act through modifying tRNAs critical for the expression of type III genes or their regulators.	2.46851e-94
NZ_CP034089.1\|WP_008783615.1\|2035209_2036778_-\|alpha-N-arabinofuranosidase	gnl\|CDD\|226064	COG3534, AbfA, Alpha-L-arabinofuranosidase [Carbohydrate transport and metabolism].	0
NZ_CP034089.1\|WP_007055364.1\|2025381_2026506_-\|FAD-synthase	gnl\|CDD\|235536	PRK05627, PRK05627, bifunctional riboflavin kinase/FAD synthetase.	5.18065e-81
NZ_CP034089.1\|WP_155661442.1\|2020765_2021806_+\|ribonuclease-HI	gnl\|CDD\|260010	cd09278, RNase_HI_prokaryote_like, RNase HI family found mainly in prokaryotes. Ribonuclease H (RNase H) is classified into two evolutionarily unrelated families, type 1 (prokaryotic RNase HI, eukaryotic RNase H1 and viral RNase H) and type 2 (prokaryotic RNase HII and HIII, and eukaryotic RNase H2). RNase H is an endonuclease that cleaves the RNA strand of an RNA/DNA hybrid in a sequence non-specific manner. RNase H is involved in DNA replication, repair and transcription. RNase H is widely present in various organisms, including bacteria, archaea and eukaryotes and most prokaryotic and eukaryotic genomes contain multiple RNase H genes. Despite the lack of amino acid sequence homology, type 1 and type 2 RNase H share a main-chain fold and steric configurations of the four acidic active-site (DEDD), residues and have the same catalytic mechanism and functions in cells. One of the important functions of RNase H is to remove Okazaki fragments during DNA replication. Prokaryotic RNase H varies greatly in domain structures and substrate specificities. Prokaryotes and some single-cell eukaryotes do not require RNase H for viability.	9.8828e-63
NZ_CP034089.1\|WP_117768520.1\|2041989_2042532_-\|50S-ribosomal-protein-L17	gnl\|CDD\|235522	PRK05591, rplQ, 50S ribosomal protein L17; Validated.	1.46962e-56

>NZ_CP034089.1|WP_007052308.1|2027768_2028242_-|30S-ribosome-binding-factor-RbfA
MAGTNPRAARIAALIQRVVASSIERELHDKRLASITVTEVRVTNDLQIAKVYWTQLGHEGHEEGERKRAQQALDQAKGHLRSLVGHKAGLRLTPQLQFVFDEVPGEAHEIEDILAVAKKRDEELARARATAQYAGDADPYKHDDEPSDDFEDDSDEE
>NZ_CP034089.1|WP_131206623.1|2026603_2027767_-|tRNA-pseudouridine(55)-synthase-TruB
MLHTTPSGLLIIDKPQGVTSFDAVAAVRGALHIKKVGHAGTLDPMATGTLVIAFGHATRLLNAIVAHDKTYEATIRLGLRTTTDDAEGEVLVDDEARSRWQTLSAQLTEGGQSGEPTALPTASWQDLLTRTIANNFTGDIEQVPNTFSAIKINGQRAYDLAREGKDVELKPRPVTISEFTVLDIRSGFVAGEQTAEPLREDANTGAIPALDVDVRISCSSGTYIRALARDLGKELGVGGYLTRLRRTRVGRFALPDDASGLIAPEAMLDTRTHTVTAHTDQKTFTNREGQTVTRNKCVLDTPEGLAGDERRNWLLDHALTMEQAARGAMPALDITPEEASELRFGRRIERTISEPTAAIVPQTHDVAAIIERANAHQAKPVTVFPLA
>NZ_CP034089.1|WP_007055364.1|2025381_2026506_-|FAD-synthase
MDITHLTPDAEGSIEWPSFSNDKKAVVTLGAFDGMHLGHQAVIKRVVELAHQHDAFSVVILFDPRPAFVHGWVISHHGEEPAVQNVDAEALTSVDDRLHRMEQFGVDHVLVVHYTLAFAAMSYIFFLGRLTGKLGMRTLVLGQDAAMGKGREGDVKHIANLAAATGVFELDVVDDRGPGEVRIPRDFKPEAPSEWGEPVDPLANATKAERRAWSKKNQAKAMRAWSSTNVRYLLAHGRIQDANAILGAPHSIEGEVVHGEERGRTIGFPTANLGSDIAGYIPVDGVYAGWLVDGENRWPAAISIGTKPTFSEKTGLNERVVEAYCITEEWIDLYDHKVRVEFVGFLRPQVKFDGPDQLVDELKRNVEETKRLTA
>NZ_CP034089.1|WP_007055359.1|2023828_2025367_+|DNA-repair-protein-RadA
MAKSSVQYVCSECGWNGPKWYGRCPECGQWGTVEEFHEARPAAGSRTAAPGRTSRTQSVTVANNARSAARPITEVGTESVERLGTGFSEFDRVLGGGVVPGSVTLIAGEPGIGKSTLLLQTAGNIARVVAGDSTFRGAGQRSAQQSGRAQGNASNTVPMRGNASSTHANTVLYISGEESQAQVRLRASRINAVEPNLLLASTTDLSTVLGLIEQNKPALAIVDSAQTIVSQEVDGISGGSTQVREVASALIDTAKTLDIPVFLVGHVTKDGSIAGPRTLEHLVDVVCQFEGDSETALRMLRAVKNRFGPTDEVGCFDMSGEGIEEVTDPAGLFLSGDGPDAANAAPVEGTCVTFTLDGHRSLPIEVQALVTTSVLPTPRRAVNGVDPSRIAMLVAVLYRHSKLNLLSNDLYISTIAGGQAKEPGSDLAIVAALASAATSKPIARATCAIGEISLTGQVRPVPRMEYRLREAARLGFTTAVIPPLRKPVHVEGLQLVESNTLSDALDALGVRK
>NZ_CP034089.1|WP_011068749.1|2023068_2023647_-|hypothetical-protein
MVVAAAVVIILAVLSAFVWPGWAIQKNDGTSTTTQNSQQKTESSEPTKPTIDATALPDDASELLKAMPGSVLNYARTKADASTTWNSASPLEEYTLTYSTGDAAKDVTLVAAQWSSADNAKTQYDALVAAQTGDESASGNVKVSGNVTGAYVVKADASNSKNAVAIWQNDTVVFQATGTKEAVDRFYQKFPM
>NZ_CP034089.1|WP_004268639.1|2022787_2022877_-|AURKAIP1/COX24-domain-containing-protein
MGSVIKKRRKRMSKKKHRKLLRKTRHQRK
>NZ_CP034089.1|WP_007052314.1|2021936_2022635_+|ribose-5-phosphate-isomerase-RpiA
MDKAQQDALKKAAGIEAAKLVENGMIAGLGTGSTVKFLVDELGRRHQEEGLEFTGVTTSRRTQAQAESYGIKIVDIDDVDHIDVTIDGADEVDKNFNGIKGGGAALLWEKIVATNSNQIVWIVDESKVVDTIGKFPLPVEVIPFGAGQVIKKFEARGYKPVLRLDADGKEVRTDENNFVVDLHLERIDHPQELAEDLINTVGVVEHGLFLNMVDKVIVGDPNGPRVMTNANK
>NZ_CP034089.1|WP_155661442.1|2020765_2021806_+|ribonuclease-HI
MMLFTLFTTLFCLALGSPTSARDCTACVRVENMTITVSTDGSALGNPNGPMGWAWADHEQNAGGKPGHKHDDHGYDAGGATNGTNQIGELCAVLEALRAHPGPEPLLIESDSQYAINCSTKWVKGWKKNGWKNSQKKPVKNKELIQAIDREISQRPGPVDFRWVKGHAGNEGNELVDELARTYAGDCRSGARDGYLPIEGWQSLLGSEYAHGTDVPPDVQLVLDGKADAASLRKPAAATDQTDAARPETKSSSPLAAQSTQPVQSTQPVQSTQPVQSTQPVQSTQPVPPAKPSGLTVSGTLTFSPAPKTSPYFNGQPMPIKGSIEIEGYVDGDGNLTITNAPFVRH
>NZ_CP034089.1|WP_011068752.1|2020415_2020763_+|hypothetical-protein
MSEASNPKRRRMNQPRPSGRPGAKAMPPGPSATVLELPAISMVPLDAAVEVEPSLSASGLRISMLPSLVLYSPLFSFQIPDAPLLPASPAERKCLVFLVSAHLFTRDGMFFKQSQ
>NZ_CP034089.1|WP_131309130.1|2018594_2020229_+|pyridine-nucleotide-disulfide-oxidoreductase
MSISTPNAISTPNTSPTITTDALIIGFGKGGKTLAAKLSAAGRKVVVAEASADMYGGTCINIGCLPSKSLILSAEQARRDGANSTPETREAAFEAAIKEKRRVTSMLRDKNYHKLADQDNITVITGRAHFTGPHSVEIATAEGPVAVTASKIFINTGATPRIPDIPGIRTTPGVYTSTGLMDLDDMPQRLVIIGSGFIGLEFASMFADFGTAVTVLQHNAEFLPREDADVAAAIRAQLEAQGVKFLFNADTKAIAPAADGGVRLSVAVKGMTRGASQACDSTPAGTGNAHTDITGATDATGATDTTTTTSPTSNPTDHATMSHVQTKPSDDGEPRFAEPAEARFCLTTDAVLVATGRTPNVEGLHLEAAGVELTERGAVKVDELLRTTAADIWALGDVNGGPQHTYISLDDYRVVWSQLNGSDRPYTVKDRKHVPSSTFLATPYSRVGLNEREAKAAGLDYVVKRLPVAAVPKAQVMRRPDGLMKAIVERNTGRILGAMLLSVESHEVINIVKLAMDLDAPASTLRDMVFTHPTIAEALNDLFA
>NZ_CP034089.1|WP_008782965.1|2031589_2032657_-|transcription-termination/antitermination-protein-NusA
MELDLTGIHKLAAEQGIDPGTLDDALAEALRLAYLKTPHAARHARVELDERSGNFTVWAADEIPVEPTEDNPYPVPKLGEEYDDTPRDFGRLAAATARQVITQLFRRAEDEKVFGAFSGQKGKLITGIIQQDASDPSNVHVAMGDVEAILPRREQVPGERYRHGERIRVYVVNVARGIKGPEIVVSRSHPELVRKLFEREVPELVSGAVSIMAIAREAGARTKIAVKANTDGVNPKGALIGPGGARVRAVMENLGPEKIDIVDYSDDPAKFVAAALSPAVATGVQVISEKNKTAIAFIHDDQLSLAIGKEGQNARLAAKLTGWKIGIESAEAHAKKVAAEKAAQAAAEAAAPEAE
>NZ_CP034089.1|WP_081049871.1|2032771_2033593_+|hypothetical-protein
MASALCASAMLCSLSACSMPRLAGRAEAEAQMTPCEKAMTLAGYATHPAEGTPLLEQYATGLAAPLAWIDVAGYCSGRFAEGTLRDAQTKQWLAFLADKFGQSAPEVTPARLDGVTSANVDRSVLDAMAVAEDRAGFAIEVLAARGQTAGATLALSDMHKTAGQQLVALANGNFDDSGAQSSSSGQNDPRQKVYAIDQLLANPTTIADKASGQTVPTAAAIEMDCARAQIKAVTESKSSTESDTLLILAALAAKHAYTAFQLGYPATDAALFE
>NZ_CP034089.1|WP_013410645.1|2033633_2034677_-|LacI-family-transcriptional-regulator
MGNRVTIKDVAREANVSIKTVSNVLNDTGSMRPDTRRRVEEVMRKLGYTVNISARAMRSGGTKLIGLNIFDFSQPFVPFFTDKVIEYAKERHYGVVINTYGSDGEGLVASVDESYRLGAEGWILFVMSPLADEGAVLEQPYPIVTTGDHLAYGKSDWITMPNIESISTVVGRFLDEGAQTVALMGVLPELVDEAVLRRQTEGTQALRAQGYVKAFEERGLSVNWRYVIPAESMNQREGMRVTKAMLDKLPCPDVVVCLNDAIALGAIHELQRCGLHVPDDVQVVGFDNVPEAEYSAPALTTIDPHIDDYAKHAVDMLIDRIEGYSGPARTYTTDFTLVERASTRLAH
>NZ_CP034089.1|WP_008783615.1|2035209_2036778_-|alpha-N-arabinofuranosidase
MSEHSHDNKPGELEESRLVVDNDFEVAPVNDRLFGSFVEHLGRCVYDGIYEPGHPEADEDGFRKDVIELVKELGATTIRYPGGNFVSGYRWEDGVGPRDERPRRLDLAWHSTETNQFGLHEMAKWLEKTGGNELMEAVNLGTRGLEEALDLLEYANIPGGTKLSEERRANGADQPFGIKMWCLGNEMDGPWQTGHKSAEDYGTLAASVAAGMRAIDPNVELVVCGSSSHVMDTFGKWEETVLEKTFDNVNFVSCHAYYHPELQPDGTRDMKSFLASGVDMDGFINDVAAAIDATKARLKSKHDVFISFDEWNVWYLNEEPSKNPEGIGNWPVAPRLLEDVYSAADAVVFGDLMITLLKNADRVHAASLAQLVNVIAPIMTEPGGPAWRQTTFYPFSLTAKLAKGGTVLEPKLASGTYETDKYGEVPTINSVAVRGEDGTISVFVVNRSMEAANDFAIKLPEGFALSAVEAQTLHEDDLLAKNTLEDQNRVVLHPNTTITSDADTGTVRVTLPPVSWTAVHVK
>NZ_CP034089.1|WP_007055304.1|2037587_2038388_-|transglutaminase-family-protein
MKKLVFDYEMRLSFSAPVTDHRFQLRCIPSTGPRQQVIDVEVKIQPETELETTIDSFDSVVMTGFIPEPHDIFSYSVTGIAFVDNAHIHKEAYKPLYRFNSALTIPGPNVEAMIAVCRERLAALPSDATPVQQAAEVMDEVYKAFVYTPGSTTIRTTAEQALAQRKGVCQDYAHVMLSVCRHVGLTARYIAGLLGGEGATHAWVEVYQDGRWVGLDPTHNRLVDDSYITIAHGRDYRDCMLDIGIFSGYNVQQSQWVNASVHEQVA
>NZ_CP034089.1|WP_155661443.1|2038594_2040775_-|UDP-N-acetylmuramate-dehydrogenase
MIESAARRLAHELVNRREAINRELSRNGVRFGIYKNGEYHDRLFPYDPVPRIIESDEYDELEKGLKQRVNALNAYLKDIYSDKRIIHDGVVPEEYVYTSAGYFPQVNCVTPPGGIFAHIAGEDLVQGEDGRWWVLEDNLRIPSGASYPLFVRDIERRISPRLFRDVRIRDNREYPRLLRKAMDFVSTEGIAVVLTPGRYNSAFFEHAYLAEKTGAALAFPEDLEVVDNKVYFLDYAGKRHRVGVVYRRLSDEFLDPFAFNPDSVIGVPGILSAYRAGNVAIVNAPGNGAADDKAVYYFVPQMIKYYLGEEPILNNAPTYMPMFEADRKEVLNRMGELVIKDVAEAGGYGVVFGSSLDAAAREELANRIKEEPRRFIVQEVIQFRDIDVVDPKTGEMSPRKCDLRAFVVTGKNTHVWYSGLTRYSSVPGQMIVNSSQGGGFKDTWVLAPESGVEHEYGAETQVANLLSQSRHHSLSLVTASKADNLYWLGRYTERAFTTLNQFFPFYDRVMDTDVDAFRPFAHALDLPEDFEDFDGFVNSFLYDGSNPDSVRSAVTSAFNNAVILRPELSSRLLQYVELAMTNITDAAKYAADAEDIYKQRDITDDMLAFWGGIENSPVDPTLKAFIFIGKYLERIDLYTRFGLTMEDLEAPLKKLAAYSMTLDGMPLPSCFADGLSWLVGQLPSRGYQEVADLLKKYLDDYSGRVSALAIKDMGSLSSMNMDAKRP
>NZ_CP034089.1|WP_007053050.1|2040996_2041908_+|tRNA-pseudouridine(38-40)-synthase-TruA
MTRLRIDLAYDGGGFYGWAKQPNLRTVQGTIEDALHKVLRVPTDDAAEPLRLTVAGRTDTGVHASHQVAHLDVSDEVLNRCVGHMTIPVTEALTRRLKAVLPSDIVIHGIAVAPVGFDARFSALERTYVYRVADRSSEVDPRLRGCVLTVDEALDLELMNRAASLTIGLHDFGSFATPNPGGTTIREVKTAYWRRVPITPLVPDEMASHEAYRTPSLESGLVVFTIVADAFARNMVRSLVGSCIKVGSGRKSLEWFAGKMAEPVREGSSGPIAPQGLTLEHIAYPADDQLAARAEAIRAVRTL
>NZ_CP034089.1|WP_117768520.1|2041989_2042532_-|50S-ribosomal-protein-L17
MPTPKKGPRLASSPAHERLMLANMATSLFQNGRITTTLPKAKRLRPLAERLITFAKRGDLHSRRRVMRVIRNKSVVHILFTQIAEQMEQREGGYTRIVKIAPRVGDAAPAAVIELVTEPVAKKAVVKEAEAAAKVAEEEAPAVEAEATEAAEAVEAPVEETAAAEAEAPAEEAADAGKAE
>NZ_CP034089.1|WP_007053048.1|2042631_2043627_-|DNA-directed-RNA-polymerase-subunit-alpha
MLIAQRPTLTEESLNPQRSRFTIEPLEPGFGYTLGNSLRRTLLSSIPGAAVTSVRISGALHEFTTLPGVQEDVTEILLNIKGIVLTSEYDEPVVMYLRKSGKGEAVAGDITPPAGVTIANPEQHIATLADDGELEIEFTVERGRGYVPAQMNKQDNDEIGRIPVDSIYSPVLKVSYKVEATRVEQRTDFDKLILDVETKPAISPRDAVASAGSTLVELFGLCRELNAQAEGVEVGPAPVAEETNPEMAVPIEDLNLTQRSYNCLKREGIHTIGELVSHTEQDLLDIRNFGMKSIDEVKEKLQTLGLSLKSSPMAFDTNNLEGGTFFSPEDE
>NZ_CP034089.1|WP_003829907.1|2043707_2044106_-|30S-ribosomal-protein-S11
MAAPKQAARKPRRRDRKSVPVGQAHIKSTFNNTIISITDPSGAVVSWASGGDVGFKGSRKSTPYAAGMAAESAARKAMEHGVKKVDVFVKGPGSGRETAIRSLQSAGLEVGSITDVTPQAHNGVRPPKRRRV

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP034089_4

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP034089_4

2172883-2172956

Orphan

Consensus_repeat	Method
AAATGACGAACCGGGACAGCGAA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP034089_4

>merge|NZ_CP034089|4|2172883-2172956|CRISPRCasFinder
AAATGACGAACCGGGACAGCGAAATCTGTCCCGGTTGTCCCAAAAGAGACGAAATGACGAACCGGGACAGCAGA

>NZ_CP034089|4|4|2172883-2172956|CRISPRCasFinder
AAATGACGAACCGGGACAGCGAA	ATCTGTCCCGGTTGTCCCAAAAGAGACG
AAATGACGAACCGGGACAGCAGA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP034089.1\|WP_117790070.1\|2168961_2170410_-\|ABC-transporter-permease	unknown	unknown	gnl\|CDD\|225669
NZ_CP034089.1\|WP_007053075.1\|2178905_2180768_-\|arginine--tRNA-ligase	unknown	unknown	gnl\|CDD\|223097
NZ_CP034089.1\|WP_022527887.1\|2171863_2172040_+\|DUF1778-domain-containing-protein	unknown	unknown	unknown
NZ_CP034089.1\|WP_117790069.1\|2170406_2171393_-\|ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|213222
NZ_CP034089.1\|WP_007053062.1\|2162688_2162997_-\|50S-ribosomal-protein-L21	unknown	unknown	gnl\|CDD\|235510
NZ_CP034089.1\|WP_007056289.1\|2175833_2177150_-\|homoserine-dehydrogenase	unknown	unknown	gnl\|CDD\|235783
NZ_CP034089.1\|WP_007056295.1\|2185332_2186658_-\|UDP-N-acetylglucosamine-1-carboxyvinyltransferase	unknown	unknown	gnl\|CDD\|236486
NZ_CP034089.1\|WP_131219790.1\|2181655_2182921_+\|MFS-transporter	unknown	unknown	gnl\|CDD\|340863
NZ_CP034089.1\|WP_007055074.1\|2159523_2160657_-\|glutamate-5-kinase	unknown	unknown	gnl\|CDD\|235460
NZ_CP034089.1\|WP_155661450.1\|2173035_2174490_-\|NUDIX-domain-containing-protein	unknown	unknown	gnl\|CDD\|178901
NZ_CP034089.1\|WP_007053061.1\|2162417_2162666_-\|50S-ribosomal-protein-L27	unknown	unknown	gnl\|CDD\|235464
NZ_CP034089.1\|WP_021975564.1\|2166529_2167804_-\|succinyl-diaminopimelate-desuccinylase	unknown	unknown	gnl\|CDD\|349899
NZ_CP034089.1\|WP_155661451.1\|2177310_2178903_-\|diaminopimelate-decarboxylase	unknown	unknown	gnl\|CDD\|143501
NZ_CP034089.1\|WP_014485295.1\|2183007_2183940_+\|LysR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|176115
NZ_CP034089.1\|WP_061870316.1\|2184033_2185287_+\|aminotransferase-class-I/II-fold-pyridoxal-phosphate-dependent-enzyme	unknown	unknown	gnl\|CDD\|224090
NZ_CP034089.1\|WP_155661449.1\|2163148_2166193_-\|Rne/Rng-family-ribonuclease	unknown	unknown	gnl\|CDD\|273254
NZ_CP034089.1\|WP_007058798.1\|2174626_2175739_-\|homoserine-kinase	unknown	unknown	gnl\|CDD\|234920
NZ_CP034089.1\|WP_060868231.1\|2180981_2181647_+\|TetR/AcrR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|224228
NZ_CP034089.1\|WP_007053060.1\|2160657_2162349_-\|GTPase-ObgE	unknown	unknown	gnl\|CDD\|237045
NZ_CP034089.1\|WP_013141357.1\|2167841_2168786_+\|AEC-family-transporter	unknown	unknown	gnl\|CDD\|223751

Protein	Function_ID	Function_description	E-value
NZ_CP034089.1\|WP_117790070.1\|2168961_2170410_-\|ABC-transporter-permease	gnl\|CDD\|225669	COG3127, COG3127, Predicted ABC-type transport system involved in lysophospholipase L1 biosynthesis, permease component [Secondary metabolites biosynthesis, transport, and catabolism].	1.52419e-06
NZ_CP034089.1\|WP_007053075.1\|2178905_2180768_-\|arginine--tRNA-ligase	gnl\|CDD\|223097	COG0018, ArgS, Arginyl-tRNA synthetase [Translation, ribosomal structure and biogenesis].	1.33981e-165
NZ_CP034089.1\|WP_007056289.1\|2175833_2177150_-\|homoserine-dehydrogenase	gnl\|CDD\|235783	PRK06349, PRK06349, homoserine dehydrogenase; Provisional.	0
NZ_CP034089.1\|WP_117790069.1\|2170406_2171393_-\|ABC-transporter-ATP-binding-protein	gnl\|CDD\|213222	cd03255, ABC_MJ0796_LolCDE_FtsE, ATP-binding cassette domain of the transporters involved in export of lipoprotein and macrolide, and cell division protein. This family is comprised of MJ0796 ATP-binding cassette, macrolide-specific ABC-type efflux carrier (MacAB), and proteins involved in cell division (FtsE), and release of lipoproteins from the cytoplasmic membrane (LolCDE). They are clustered together phylogenetically. MacAB is an exporter that confers resistance to macrolides, while the LolCDE system is not a transporter at all. An FtsE null mutants showed filamentous growth and appeared viable on high salt medium only, indicating a role for FtsE in cell division and/or salt transport. The LolCDE complex catalyzes the release of lipoproteins from the cytoplasmic membrane prior to their targeting to the outer membrane.	6.81137e-100
NZ_CP034089.1\|WP_007053062.1\|2162688_2162997_-\|50S-ribosomal-protein-L21	gnl\|CDD\|235510	PRK05573, rplU, 50S ribosomal protein L21; Validated.	3.48911e-33
NZ_CP034089.1\|WP_007056295.1\|2185332_2186658_-\|UDP-N-acetylglucosamine-1-carboxyvinyltransferase	gnl\|CDD\|236486	PRK09369, PRK09369, UDP-N-acetylglucosamine 1-carboxyvinyltransferase; Validated.	0
NZ_CP034089.1\|WP_131219790.1\|2181655_2182921_+\|MFS-transporter	gnl\|CDD\|340863	cd06173, MFS_MefA_like, Macrolide efflux protein A and similar proteins of the Major Facilitator Superfamily of transporters. This family is composed of Streptococcus pyogenes macrolide efflux protein A (MefA) and similar transporters, many of which remain uncharacterized. Some members may be multidrug resistance (MDR) transporters, which are drug/H+ antiporters (DHAs) that mediate the efflux of a variety of drugs and toxic compounds, conferring resistance to these compounds. MefA confers resistance to 14-membered macrolides including erythromycin and to 15-membered macrolides. It functions as an efflux pump to regulate intracellular macrolide levels. The MefA-like family belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.	6.28174e-50
NZ_CP034089.1\|WP_007055074.1\|2159523_2160657_-\|glutamate-5-kinase	gnl\|CDD\|235460	PRK05429, PRK05429, gamma-glutamyl kinase; Provisional.	4.59837e-176
NZ_CP034089.1\|WP_155661450.1\|2173035_2174490_-\|NUDIX-domain-containing-protein	gnl\|CDD\|178901	PRK00148, PRK00148, Maf-like protein; Reviewed.	1.62433e-59
NZ_CP034089.1\|WP_007053061.1\|2162417_2162666_-\|50S-ribosomal-protein-L27	gnl\|CDD\|235464	PRK05435, rpmA, 50S ribosomal protein L27; Validated.	3.06993e-50
NZ_CP034089.1\|WP_021975564.1\|2166529_2167804_-\|succinyl-diaminopimelate-desuccinylase	gnl\|CDD\|349899	cd05647, M20_DapE_actinobac, M20 Peptidase actinobacterial DapE encoded N-succinyl-L,L-diaminopimelic acid desuccinylase. Peptidase M20 family, actinobacterial dapE encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) subfamily. This group is composed of predominantly actinobacterial DapE proteins. DapE catalyzes the hydrolysis of N-succinyl-L,L-diaminopimelate (L,L-SDAP) to L,L-diaminopimelate and succinate. It has been shown that DapE is essential for cell growth and proliferation. DapEs have been purified from proteobacteria such as Escherichia coli and Haemophilus influenzae, while genes that encode for DapEs have been sequenced from several bacterial sources such as the actinobacteria Corynebacterium glutamicum and Mycobacterium tuberculosis. DapE is a small, dimeric enzyme (41.6 kDa per subunit) that requires 2 atoms of zinc per molecule of polypeptide for full enzymatic activity. All of the amino acids that function as metal binding ligands are strictly conserved in DapE.	0
NZ_CP034089.1\|WP_155661451.1\|2177310_2178903_-\|diaminopimelate-decarboxylase	gnl\|CDD\|143501	cd06828, PLPDE_III_DapDC, Type III Pyridoxal 5-phosphate (PLP)-Dependent Enzyme Diaminopimelate Decarboxylase. Diaminopimelate decarboxylase (DapDC, EC 4.1.1.20) participates in the last step of lysine biosynthesis. It converts meso-2,6-diaminoheptanedioate to L-lysine. It is a fold type III PLP-dependent enzyme that contains an N-terminal PLP-binding TIM-barrel domain and a C-terminal beta-sandwich domain, similar to bacterial alanine racemases. DapDC exists as homodimers with active sites that lie at the interface between the TIM barrel domain of one subunit and the beta-sandwich domain of the other subunit. Homodimer formation and the presence of the PLP cofactor are required for catalytic activity.	3.77624e-72
NZ_CP034089.1\|WP_014485295.1\|2183007_2183940_+\|LysR-family-transcriptional-regulator	gnl\|CDD\|176115	cd08423, PBP2_LTTR_like_6, The C-terminal substrate binding domain of an uncharacterized LysR-type transcriptional regulator, contains the type 2 periplasmic binding fold. LysR-transcriptional regulators comprise the largest family of prokaryotic transcription factor. Homologs of some of LTTRs with similar domain organizations are also found in the archaea and eukaryotic organisms. The LTTRs are composed of two functional domains joined by a linker helix involved in oligomerization: an N-terminal HTH (helix-turn-helix) domain, which is responsible for the DNA-binding specificity, and a C-terminal substrate-binding domain, which is structurally homologous to the type 2 periplasmic binding proteins. As also observed in the periplasmic binding proteins, the C-terminal domain of the bacterial transcriptional repressor undergoes a conformational change upon substrate binding which in turn changes the DNA binding affinity of the repressor. The genes controlled by the LTTRs have diverse functional roles including amino acid biosynthesis, CO2 fixation, antibiotic resistance, degradation of aromatic compounds, nodule formation of nitrogen-fixing bacteria, and synthesis of virulence factors, to a name a few. This substrate-binding domain shows significant homology to the type 2 periplasmic binding proteins (PBP2), which are responsible for the uptake of a variety of substrates such as phosphate, sulfate, polysaccharides, lysine/arginine/ornithine, and histidine. The PBP2 bind their ligand in the cleft between these domains in a manner resembling a Venus flytrap. After binding their specific ligand with high affinity, they can interact with a cognate membrane transport complex comprised of two integral membrane domains and two cytoplasmically located ATPase domains. This interaction triggers the ligand translocation across the cytoplasmic membrane energized by ATP hydrolysis.	3.38254e-32
NZ_CP034089.1\|WP_061870316.1\|2184033_2185287_+\|aminotransferase-class-I/II-fold-pyridoxal-phosphate-dependent-enzyme	gnl\|CDD\|224090	COG1168, MalY, Bifunctional PLP-dependent enzyme with beta-cystathionase and maltose regulon repressor activities [Amino acid transport and metabolism].	7.64705e-121
NZ_CP034089.1\|WP_155661449.1\|2163148_2166193_-\|Rne/Rng-family-ribonuclease	gnl\|CDD\|273254	TIGR00757, Ribonuclease_E/G-like_protein, ribonuclease, Rne/Rng family. This model describes ribonuclease G (formerly CafA, cytoplasmic axial filament protein A), the N-terminal domain of ribonuclease E in which ribonuclease activity resides, and related proteins. In E. coli, both RNase E and RNase G have been shown to play a role in the maturation of the 5' end of 16S RNA. The C-terminal half of RNase E (excluded from the seed alignment for this model) lacks ribonuclease activity but participates in mRNA degradation by organizing the degradosome. [Transcription, Degradation of RNA].	7.11448e-154
NZ_CP034089.1\|WP_007058798.1\|2174626_2175739_-\|homoserine-kinase	gnl\|CDD\|234920	PRK01212, PRK01212, homoserine kinase; Provisional.	4.23972e-87
NZ_CP034089.1\|WP_060868231.1\|2180981_2181647_+\|TetR/AcrR-family-transcriptional-regulator	gnl\|CDD\|224228	COG1309, AcrR, Transcriptional regulator [Transcription].	9.55735e-17
NZ_CP034089.1\|WP_007053060.1\|2160657_2162349_-\|GTPase-ObgE	gnl\|CDD\|237045	PRK12296, obgE, GTPase CgtA; Reviewed.	0
NZ_CP034089.1\|WP_013141357.1\|2167841_2168786_+\|AEC-family-transporter	gnl\|CDD\|223751	COG0679, COG0679, Predicted permeases [General function prediction only].	1.81975e-36

>NZ_CP034089.1|WP_022527887.1|2171863_2172040_+|DUF1778-domain-containing-protein
MTSLQWALSNLLAAADRDIHEAHIIRLNSKAWNDFTAALNEPMGLRLNELLERDPIWT
>NZ_CP034089.1|WP_117790069.1|2170406_2171393_-|ABC-transporter-ATP-binding-protein
MQQPQPAPGPAAQPQQSQQPQQFQQPASHTQQWAPVIEAHDLVMDYTASMARAQAGHGVTGVMPAGTGAGYASANPAAAGPGAIQAGQPSQPAQPGFAMPTMHTLALNHVNFTLREGETVAVMGPSGSGKSTLLHALAGIIKPTAGTVVFRGTDLSHMSDADRTKLRRNVFGFVFQSGQLLPELPAVENIALPMMLDGVPYRTATDTAILWLERMGLRALAMHRPGEMSGGQMQRIAIARALAVKPAVVFADEPTGALDQATGREVMGILMAAARDNGSAVVVVTHDPNVASFCGRTVMMQDGRLHQTGANHNFAPAGGSETNAGGAR
>NZ_CP034089.1|WP_117790070.1|2168961_2170410_-|ABC-transporter-permease
MSTFALWRLFHRPGSRGSAGHTSMLAIIAFAAATTIFLTVLGGVHGFIWRASADHTVACAFDLGACRPDTVAAWKRQISDPTNLAQFSTAYVVLAVFACMLLVVPFVALAGSAARLAASRRDARLAALRLAGATTGQVVRLTALDAAGQALIGALIGIAGYCALMPAVMLIPFQEQRFTFEQLWVGPLALVITLAGVAILALISSLVTLRRVAITPLGVTSRTATALPSGTRMVLFVVVMVAAVIVFKNPAMLPQAGQAVMDAVIIGFMLLCFALVNLIGTWVVTARAKAKAKRPKDAATMIAMRRILDNPKRAWRNVSGIALAVFIAGITSICGFFGSAAVAGDANDPSTVFIRDIGTGGILTLVFAAVLAAVSSGVMQAGSVYDQAGEYRMLVLEGTDVKTLNRARFIEVLTPLNIVVIVAGGCSMLLMAPLFAASMTEPATLASFFGGLVLCYALVSVGAFASNRVAASLNLTDYRADD
>NZ_CP034089.1|WP_013141357.1|2167841_2168786_+|AEC-family-transporter
MSGLISAMQGFCVIGIVIAVGYVAARMRIGGPSAQMVLNRFSFFVSSPCLMFAILSKEPIFDIFHPSIIVAFFSAVLVGVVFLVLNRMFFHLNAPDATIGALNSLYLNSNNIGLPIATYILGNPALVAPILVMQQAIFTPVGLTVLDVTTKGKVSIKEIAKQPLHQPLLIGSLLGIVVSAISAKSGWFPVPKFIFDPIDMIGDSAVPMILMAFGMSLHGTKPLQQKGDRPAIFTVAVLKNIIMPIIAFLLAYFVMGFRGSELYACVVLAALPTGQNVYNYAARYNVGLTFARDGILMSTMTSPVFIAIIAALLS
>NZ_CP034089.1|WP_021975564.1|2166529_2167804_-|succinyl-diaminopimelate-desuccinylase
MYSAAKSHVVSVLGPPPTRYAVHMTLELNRTASTAEQLNSLLTQIMENFSVSDHEGPLTDEVEAFLNEQEHLTVRRHGDTVVASTDFGKPSRVILAGHLDTVPVIDNFPPKWLEPGDSLIREEIAHAHPEDRVLWGRGATDMKASDAVMLYLAATLDGRTPETTPKVDLTYVFYDHEEVVAEKNGLRKVVEAHPDWITGDFAIIGEPTNSGIEGGCNGTIRFDVVTHGVAAHSARAWMGENAIHKAADILNRLNAYEPATVNVDGLDYREGLNATLISGGKGTNVIPDECRVHVNYRFAPDKSLAEAKALMMGADAGAELGNGEHVATGGVFEGYGIEMKDESPSARPGLNAPLAQDLVRLVKERTGRDPLAKLGWTDVARFSQLGIPAVNLGAGDPLLAHKHDEQVPESDLTAMAAILTDWLV
>NZ_CP034089.1|WP_155661449.1|2163148_2166193_-|Rne/Rng-family-ribonuclease
MPTDNREGFVNDGTDNSTVSNADSAAAVNAAPAAASQPAEPVRRRRGGRRVVRGTGAAGASLELQVQERAPLFEAPALPDAGTAADSKSADSSDSDESSDSQDSAERPTRRRSRRAASAVADSDSEDDRPRRSRRTVSADDFDDDDAPRSRRRSVVDDDDYDEDRPVRRRSRSRQSDDDDYEDRPVRSRSRRASMDMDDDDEDRPVRRRSRRAVADTHEDTPDERLFDAVESLPSGHEAVRRGKPMTSLLFQEPVLPAAVDAHDTADTRDDDVDDDERPSRRSRRSRSHDDDDAQPRSRRRDDRDDRGRNAADRDASRDASRNAAAGDANASANTDHDDFDSDDASDSRRSRRSRRLNAQERRAAAEVEQIEEDLELDDIAYSPIAEEEGDEESDATRARSRRRRRRGSRGETGANGEHDTAENDAEDTRSRRRDDRDDHDRDRDEDDEEQTVTRRRRRRRGGKNGEGTDDQSQNSEQPLVRRSRKQQYIDEITDVEGSTRLEAKKQRRRDNRRERSRQSQLMEQDFLARRENVDRLMVVREKEHHTQISVVEDNVLVEHYVSDIQEVQTVGNIYLGRVQNVLPSMEAAFVDIGQARNGVLYAGEVNWDAARLEGQPRRIELAFKSGDPVLVQVTKDPIGHKGARLTSQVTLAGRFLVLVPSGGMTGVSRKLSERERSRLKNIVSKIAPKDMGVIIRTAAEGASEDAIVKDLESLVRQWERINAKREEFWHGKRPKLLQGEPDVAIRVVRDIFNDDFSKLIVEGDKVYDRIEEYLDTMAPDLKDKLEKWDPAEHEGKDVFDKWSIDSQLRKGMERQVYLPSGGSIVIDRTEAMTTIDVNTGRFIGKGKSLEETVTRCNLEASEEIARQLRLRDIGGMVMIDYVDMVMPANRDLVLRRLVECLARDRTKHQVAEVTSLGLVQMTRKRIGQGLVEAFSEECPTCKGRGFILHDQPTVSADYDDPYALRGGDPFVKTNKHGRGTAPAPEPAGSSADVKAKLAQIAAAAVAANNTAEE
>NZ_CP034089.1|WP_007053062.1|2162688_2162997_-|50S-ribosomal-protein-L21
MYAIVKAGGHQEKVEVGDVILVNRLDAKKGDTVEFPVSLVVDGDKVTLAAADLAKVSVKAEVVNDEAKGPKISIQKYKNKTGVARRKGHRQKLTIVKITAIA
>NZ_CP034089.1|WP_007053061.1|2162417_2162666_-|50S-ribosomal-protein-L27
MAHKKGASSSRNGRDSNPQYLGVKKFGGEAVVAGNIIVRQRGTNFHPGHNVGMGKDHTLFALTDGSVKFGVRRDRKVVDVIA
>NZ_CP034089.1|WP_007053060.1|2160657_2162349_-|GTPase-ObgE
MSDFVDRVTVHVKGGDGGNGSAGIRREKYKPLAGPNGGNGGDGGSVVFVADRNATSLLDYRFMPHRVAGSGTMGLGDNKDGSKGEDLILPVPCGTVVFEARGEQGKAKHPGAQLADLRHEGDRCVVAQGGAGGLGNIALANKTRRAPGFALLGELGEERDVILELKSIADVALVGFPSAGKSSLIAAMSSAKPKIADYPFTTLVPNLGVVIAGDSRYTIADVPGLIPGASEGKGLGLEFLRHIERTEIIAHVIDCATLEPDRDPMSDYHALENELALYADKLELPLGAIPIPERPRIVILNKIDVPEAKELAEFVRPEFEKLGLKVFEISTASHEGLKELNFALSALVHEMREEVANREQAEEEARVVIKPLETKGRRPRRADEGGSALEFTVERRELGNGEVFFEVRGVKPERWVMQTNFDNDEAVGYLADRLAKLGVEDELRRKGAHPGDEVRIGRGARMVEFDWDPTISAGAEMLDGSNLGARGKDLRLEELDPRTHRRSNAERRAQYHEMMDARAAVRDAMMAERKAGHWADPTVDDDRHDETSLFGHGESSEDGETEE
>NZ_CP034089.1|WP_007055074.1|2159523_2160657_-|glutamate-5-kinase
MSTPSQAEVRRMIAAAGTIVVKVGSSSLTQPSGHLDPDKLDALAAALAQVRLMGGRVVLVSSGAIAAGFGPLGFDSRPVDVATQQATAAVGQGLLMARYETAFGRFGIRVGQILITAEDTIRATQYRNVERTLDRLLDLGVVPIINENDSLASNEIRFGDNDRLSALVANLVRAEALVLLTDVDALYTAPPSQPGSRRVEYVPNVIDALGDIQVSGSGSKVGTGGMVTKLEAARVAAVSGIPTVLTCASNAGPAMMGDPVGTVFAPVKARGSSRRLWIGFAADPRGTIVVDAGAGQAIRGGRASLLAAGALEVHGDFSAGDPVWIDAESGEHLARGLAGFDSEEIPQMLGRNTAQLKRFLGPQYAHPLVHRDNLVLV
>NZ_CP034089.1|WP_155661450.1|2173035_2174490_-|NUDIX-domain-containing-protein
MPIPLILASKSKPRRDVLYSAGICPTIRVSHVDEPAALEAAAREEGVTVDDLSIKQRVMILAAAKAEAVHRAYRDVADTAAAATGDRVIAYPLKAKEIKDSEREAAVEDLREAAAGKPIDYSKAEIATTRDFSGIDMPTVTEPIATAIAGQPGLTEATVGPLILGCDSMFLLGGECYGKPHSEAVARERLKRMSGATGELWTGHCLIDFATGRTVRGASHAKVHFGEFTDADVERYIATGEPLEVAGSFTLEGFGGAFIDSIEGDPHGIIGLSLPLARHLAGELGITWTDLWNVGRGELEPESKASGNQHAGILPPVENVHQPGDGWVDCACGRKHWGTNGASGILLARRDPVSGKVTHVVMQHRAAWSAEGGTWGIPGGATVDGESPIEGALRESYEEANITPEDIEVVGSYREDHGPWAYTTVFAFEKPGHTVEPKANDDESMEICWVPIDDVPNRKLLTAMKTDWPRFAARLDELACAGHR
>NZ_CP034089.1|WP_007058798.1|2174626_2175739_-|homoserine-kinase
MNPICNSVHVRVPATSANLGSGFDTVGLALDYHDELTFTLNDDPNDGIAHVIIHGEGADALPCDETHLVVSTFRRACATFGLGRLGFTLEATNNIPQARGMGSSAEAIVAGIAAAAAFAQTGDLNRPAVFDMAAQIEGHPDNVAPAVFGGLTVSWDFETAEGVGSVAVPGGEPLHGGFHAVNYPVDPSITAAVFVPDYELSTEKARQALPRELPYKDAVYNVSRVGLLPAAMNPVVLAQAAQQGKSGVAAAPAQDADTCACSGGTRESAFADELAAAQAQSNALLFTATQDKLHQPYRGALMPPSTELIALFRSKGYAAAVSGAGPCVLVLHYGNAREAIDQIASEQLASGHWRVLHLPINTAGVEIERR
>NZ_CP034089.1|WP_007056289.1|2175833_2177150_-|homoserine-dehydrogenase
MARNNETPIRVGLLGAGTVGSQTARLIVEQKDELSARIGRPVELTGVACLDPKETEKFPWIDQSIVTTDTLSVATNSDIVIELIGGTTVARKFVLAAIESGASVVTANKALLAKYGPEIYSAAEAKGVDIYFEAAVGGAIPFLRPLRESLVGDKVTSMLGIVNGTTNYILDEMTTKGLQFDDVLKDAQAKGYAEADPTGDIEGYDAANKAAIMATLGFHTSVTIDDVSVEGITKITADDIAAATAEHKVIKLLAVVENGEAGVSARVYPALIDENHPLASVHGSFNAVFVKAEAADDLMFYGRGAGGAPTASAVVGDVVTEARHIAAGCTGPSIPLYKNLPKAPITASKAAFAVRFLIHDKPGVLAAIAAEFAKNGVSINGVNQDLKPTMTDPGYDGEIQQLRVVTHLTDEETLRNTVKAVQALDFVTGDPSILRVLD
>NZ_CP034089.1|WP_155661451.1|2177310_2178903_-|diaminopimelate-decarboxylase
MPISPIWPAATAVNAEGSIEFHGRTAESLLDEFGSPLYLIDTDEVVARARHFVRAAAEAFNTSTTHVSFAGKAFLSKEVVRLVTETGMFVDTCTMGEMKIALAAGVPGRRLVLHGNNKSDEEIALAIEQGFAKIVIDEPDEPERVAAIARKLGKRARVMLRVTVGVHAGGHEYISTAHEDQKFGVPLLAAGADAAVLDVLNDLKDVTPAATNARISATHSPENGAEKTEKSERELHYDVKYPYDLSHEEVSDADKALAAAMEAIADGPSIAVLKTILANQDVLELVGAHSHIGSNIHDADAFIHAAKRMMLLRKTLWATDAYILPEIDLGGGYSVAYTDGEDSMDIDVELTRLADAVNSTNRALGMPAPAISFEPGRYIVAPAGVTLYRVGTIKHVHLSDAKDSDGNPIAERVYVSVDGGMSDNIRPALYGADYTARLANRTGSAETMLARVCGMHCESGDIVVHEVQLPADLKRGDILAVPVTGAYGRTMASNYNQALIPAVVAVSESGAHVMLRRQTVDDLLNLDVSE
>NZ_CP034089.1|WP_007053075.1|2178905_2180768_-|arginine--tRNA-ligase
MSPEALSELISSIAHNLVAAGQAGALTDELIPPVDKLAVMRPKDRAHGDWASNIAMQLAKKAGMKPRDLAEPFAAALAEADGIAKVEVAGPGFINITLDSASAAAVVDTVLAAGAVTDADKHLNKVNEYGRNDHLGGQTLNLEFVSANPTGPIHIGGTRWAAVGDAMARVLEANGAKVVREYYFNDHGEQINRFAKSLVAAWAEANNLGEAGYQTETPCDGYKGAYINEIAARVQAEAESDGVDLTALAHQDQGLNDDGEPLGEADTEVREEFRKRAVPMMFDEIQKSMKDFRVNFDVWFHENSLYADGKVDAAIEELKSRGDIFDKDGATWFESTKHGDDKDRVIIKSNGEFAYFAADIAYYWDKRHRAENSADVAIYMLGADHHGYIGRMMAMCAAFGDEPGKNMQILIGQLVNVMKDGKPVRMSKRAGNVVTIDDLVSVVGVDAARYSLARSDYNQNFDIDLALLASHTNDNPVYYVQYAHARSKNVDRNAAAAGISYEGADLALLDTEADGEVLAALAQFPSVLATAADDRQPHKVARYLEELAATYHKWYNVERVVPMALTDPETRGDDEARKALEIAKNPEPARAAARLKLNDAVQQVIANGLDLLGVTAPEKM
>NZ_CP034089.1|WP_060868231.1|2180981_2181647_+|TetR/AcrR-family-transcriptional-regulator
MARNTHPEVTRTRILDAAQRLFMAQGYEHTSIQNIVDELGDLSKGAIYHHFKSKEAILEELINRDNNVQDDFNESVMNRTDLTALEKFRVLWRHSMTEQDHVQIMRAAMPMLSDPVSFAANMQVWSKHLPERFLPLIEAGVKDGSIPTEYPREAAELLSLLPNYWLMPYFYPATLPEMEHRIRCLATMLDAIGVPIFDDELITVAAKGMMTFAGEPEKGSE
>NZ_CP034089.1|WP_131219790.1|2181655_2182921_+|MFS-transporter
MKPENDIAGTATQRPLLSRDFVLLVAGQGISLFGNMMLRFAMSMWVLDKTGSATIFASVLAISIVPTILLSPFGGVLADRVNRRTIMVALDAISAVLVLASAIVFATTGFHIVAIATMQVLLAVLGAFETPTVQAALPQMFRQYGPATMRQGMAVINQVQQLSSLLPSFLGGVLYAMFGIRLMMIIAIASFAGAAALECFIRLSAPDRGDEELPTPLEDLKAGVRFLIKDRPNVFRLLLFAAALNFVLIGYSGVGFPYTIRTVLGFDATVYGIADGLIGVSGVAGAFIAGLFAAKLTMRWLPGLMATLTLAMVPQGIVFLLPVDAWTKLVVLIVFTCGTMVASCFTNLIAVPAIQLSTPEAMAGKVMSMAAAVSMCAQPLGQMVYGWAYDQMPVAIVLFITTALFAVLTVLMVPLAKQFED
>NZ_CP034089.1|WP_014485295.1|2183007_2183940_+|LysR-family-transcriptional-regulator
MATLNPQSLVTLWQIEQYGSFSATAKATGWSQPAISQQIKKLEAQCGSTLVQRTSHGVELTATGSMLARHGEAIADRLERAAREVEDYRHHRFDHLHLVAPPSICSTIAARTVVKLSMFTDIELSLIQMEPPEAIGLISQGKADAAAVFRYSSIPNFLHIGDDLTFHSLGYDPMRLLVRRSSGIAKRFEETGEPVPLSAAKDEHWIAGCPTCRANLVKLATRAGFKPDIRHCTDDYWATQNLVEVGMGVSLVPALDTHINLQGDLVACPIADDFAAREVGIVTRAGDHRPALGSLLEELERTSLKYLSAK
>NZ_CP034089.1|WP_061870316.1|2184033_2185287_+|aminotransferase-class-I/II-fold-pyridoxal-phosphate-dependent-enzyme
MSMNNIPQSTTLSNTTAGTSCFDANHIDVTTIEDLEQVGSDKWTRYPGCIGAFIAEMDYGLAPCVAEAIEEATERGALGYIPDPWKKEVARSCAAWQRRYGWEVDPTCIRPVPDVLEAFEVFLREIVRAGNSIVVPTPAYMPFLSVPRLYGVEVLEIPMLCAGAGESSGRNDEWLFDFDAIEQAFANGCHAFVLCNPHNPIGKVLTREEMLRLSDLAAKYNVRIFSDEIHAPFVYQGHTHVPFASINRQTAMQAFTSTSASKSFNIPGTKCAQVILTNPDDLELWMRNAEWSEHQTATIGAIATTAAYDGGAAWFEGVMAYIERNIALVNEQMRTRFAKVRYVEPQGTYIAWLDFSPLGIDDPANYFFKKANVALTDGRECGEVGRGCVRMNFAMPYPLLEECFDRMAAALEADGLL
>NZ_CP034089.1|WP_007056295.1|2185332_2186658_-|UDP-N-acetylglucosamine-1-carboxyvinyltransferase
MAENPDDVLHVEGGKPLNGTIKVRGAKNFVSKAMVAALLAPGKSVLKNVPEIRDVHVVSDLLRLHGVDVDVDGANGIVTIDASRVQLADVADVDTLSGSSRIPILFSGPLVHRLGEAFIPALGGCAIGGRPIDFHLETLRKLGATVDKEHKDGIHITAPNGLHGAKIHLPYPSVGATEQTLLAAVLAEGKTELSGAATEPEIMDLVCVLQKMGAIISVDVDRTFRIEGVKELQGYTHTSLTDRIEAASWASAALATHGDIFVKGATQPEMITFLNVFRKVGGKFEVTDKGIRFWHPGGDLKPVAIETDVHPGFMTDWQQPLVVALTQANGLSIVHETVYENRFGFTKPLVEMGATIQLYRECLGSLPCRFRQRNYKHSAVIFGPTPLTGRDIDVPDLRGGFSHLIAALAASGPSDVHGISLIDRGYADFRGKLEALGADFD

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Self-targeting detection

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_ID	Protospacer_location	Mismatch	Identity

MGE targeting detection<

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_phage_ID	Hit_phage_def	Protospacer_location	Mismatch	Identity
NZ_CP034089_2	2.1\|841638\|27\|NZ_CP034089\|CRISPRCasFinder	841638-841664	27	NC_015513	Haliscomenobacter hydrossis DSM 1100 plasmid pHALHY03, complete sequence	20971-20997	4	0.852
NZ_CP034089_2	2.1\|841638\|27\|NZ_CP034089\|CRISPRCasFinder	841638-841664	27	MN694668	Marine virus AFVG_250M472, complete genome	7746-7772	6	0.778

1. spacer 2.1|841638|27|NZ_CP034089|CRISPRCasFinder matches to NC_015513 (Haliscomenobacter hydrossis DSM 1100 plasmid pHALHY03, complete sequence) position: , mismatch: 4, identity: 0.852

ggaaaacggcggaaacaagccaaaatc	CRISPR spacer
ggaatacgccggaaacaagccaaaacg	Protospacer
**** *** ****************.

2. spacer 2.1|841638|27|NZ_CP034089|CRISPRCasFinder matches to MN694668 (Marine virus AFVG_250M472, complete genome) position: , mismatch: 6, identity: 0.778

ggaaaacggcggaaacaagccaaaatc	CRISPR spacer
aagaaacggaagaaacaagccaaaatg	Protospacer
...****** .***************

Prophage detection

Region	Region Position	Protein_number	Hit_taxonomy	Key_proteins	Att_site	Prophage annotation

Anti-CRISPR protein detection

Acr ID	Acr position	Acr size	Homology with known anti	Neighbor HTH/AcRanker	Neighbor Aca	In prophage	Protospacer in prophage